Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,1.8272324187725993e-43,28.446121217065013,2799.3360382290957,"['RPL4', 'RPL5', 'RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS17', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPS6KA2', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPL23', 'RPS5', 'RPS6', 'RPL22', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL28', 'UBA52', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPL18', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS6KB1', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",9.592970198556145e-41,0,0,73
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,8.487796874606196e-12,4.741855171432636,120.8812291577904,"['NDUFB9', 'COX7B', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB6', 'NDUFA12', 'NDUFB5', 'COX4I1', 'NDUFB4', 'COX17', 'NDUFB3', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'COX7A2', 'UQCR11', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'ATP5MC1', 'ATP5IF1', 'ATP5F1B', 'ATP5MF', 'ATP5ME', 'COX8A', 'ATP5PF', 'ATP5PD', 'NDUFA6', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'COX6C', 'ATP5F1E', 'COX6B1', 'NDUFS6', 'NDUFS5', 'NDUFAB1', 'SLC25A4', 'SLC25A6']",2.2280466795841263e-09,0,0,42
3,Oxidative phosphorylation WP623,3.805855794207426e-07,4.5514609421586165,67.27766920854512,"['NDUFB9', 'ATP5PF', 'NDUFB7', 'NDUFA6', 'ATP5PD', 'NDUFA11', 'NDUFB10', 'NDUFB6', 'NDUFB5', 'NDUFA4', 'NDUFB4', 'NDUFA3', 'NDUFA2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'ATP5F1E', 'ATP5MC1', 'ATP5F1B', 'NDUFS6', 'NDUFS5', 'NDUFAB1', 'ATP5MF', 'ATP5ME']",6.660247639862996e-05,0,0,24
4,Nonalcoholic fatty liver disease WP4396,5.697584344567718e-06,2.5034179121770364,30.22994357042749,"['NDUFB9', 'NDUFA13', 'COX7B', 'GSK3A', 'NDUFB7', 'NDUFA11', 'UQCRB', 'NDUFB10', 'NDUFB6', 'NDUFA12', 'NDUFB11', 'NDUFB5', 'COX4I1', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'LEPR', 'RAC1', 'COX8A', 'JUN', 'TGFB1', 'NDUFA6', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'COX6C', 'COX6B1', 'NDUFS6', 'NDUFS5', 'NDUFAB1', 'CYCS', 'PPARA', 'ATF4']",0.000747807945224513,0,0,41
5,Mitochondrial complex I assembly model OXPHOS system WP4324,1.863886944619736e-05,3.69156346749226,40.20209114518422,"['NDUFB9', 'NDUFA13', 'NDUFB7', 'NDUFA6', 'NDUFB10', 'NDUFB6', 'NDUFA12', 'NDUFB11', 'NDUFB5', 'NDUFB4', 'NDUFA3', 'NDUFB3', 'NDUFA2', 'NDUFB2', 'NDUFA1', 'NDUFB1', 'NDUFS6', 'NDUFS5', 'NDUFAF4', 'NDUFAB1', 'TMEM126B']",0.0016785151997092615,0,0,21
6,Mitochondrial CIV Assembly WP4922,1.9183030853820132e-05,5.2651014109347445,57.18681725742675,"['COX8A', 'COA3', 'COX7B', 'PET100', 'NDUFA4', 'COX4I1', 'COX17', 'COX7A2', 'COX5B', 'COX6C', 'COX7C', 'PET117', 'COX6B1', 'COX14', 'COX10']",0.0016785151997092615,0,0,15
7,Pathways in clear cell renal cell carcinoma WP4018,0.0018432073725279927,2.3452364199268225,14.766190323976986,"['SETD2', 'KDM5C', 'CREBBP', 'TGFB1', 'BHLHE41', 'PLOD2', 'ENO2', 'ACACB', 'ACACA', 'VEGFA', 'RPTOR', 'ACLY', 'LDHA', 'PKM', 'ZEB1', 'PGK1', 'EP300', 'CDH13', 'ALDOC', 'CEP290', 'PFKP']",0.13824055293959944,0,0,21
8,Glycolysis and Gluconeogenesis WP534,0.00302747679513668,3.3707969712525667,19.550709222054753,"['LDHA', 'PDHA1', 'PKM', 'GOT1', 'MDH2', 'MPC2', 'PGAM1', 'PGK1', 'ALDOC', 'ENO2', 'PFKP']",0.19867816468084462,0,0,11
9,Nuclear receptors WP170,0.0054285167366726365,3.267316572601334,17.042615155158465,"['RXRB', 'ESRRA', 'THRA', 'NR1H2', 'RORA', 'ROR1', 'PPARG', 'NR2F2', 'PPARA', 'RXRG']",0.3149138944683682,0,0,10
10,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.005998359894635585,3.91881086622245,20.049691327701645,"['EGLN1', 'LDHA', 'PDHA1', 'RPS6', 'PDHB', 'ACACB', 'ACACA', 'VEGFA']",0.3149138944683682,0,0,8
11,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.007338209517428242,4.284900102459017,21.058828856087388,"['TJP1', 'JUN', 'ITPR1', 'PLCG1', 'LPP', 'PTK2', 'MYLK']",0.3314583284196613,0,0,7
12,Parkinson's disease pathway WP2371,0.007758499320308624,2.837674267805036,13.788163779658271,"['PRKN', 'ATXN2', 'PINK1', 'UBB', 'CASP6', 'HTRA2', 'CASP2', 'CYCS', 'UBE2G1', 'PARK7', 'SNCAIP']",0.3314583284196613,0,0,11
13,Airway smooth muscle cell contraction WP4962,0.00870728024592196,4.895545314900153,23.22248816204045,"['RYR1', 'PPP1R14A', 'ROCK2', 'GNAQ', 'CALM1', 'MYLK']",0.3314583284196613,0,0,6
14,Angiogenesis WP1539,0.008838888757857634,3.5621825637202367,16.844115512204002,"['CREBBP', 'ANGPT1', 'TIMP2', 'TIMP3', 'PLCG1', 'PTK2', 'FGFR2', 'VEGFA']",0.3314583284196613,0,0,8
15,MECP2 and Associated Rett Syndrome WP3584,0.010717436027754263,2.0539879946802775,9.31664990193179,"['GRIA1', 'MPP1', 'RBFOX1', 'ARHGEF26', 'GRID1', 'DLX6', 'RPS6', 'TET2', 'UBE3A', 'IGF1R', 'MAG', 'SP3', 'NF1', 'MBP', 'SGK1', 'CDON', 'FKBP5', 'GRIA4']",0.3751102609713992,0,0,18
16,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.013245959947894051,2.939076923076923,12.708752844477054,"['ATF1', 'CREB3', 'CAMK1D', 'ATF6B', 'GNAQ', 'ITPR1', 'CALM3', 'CALM1', 'ATF4']",0.40465130774276853,0,0,9
17,VEGFA-VEGFR2 Signaling Pathway WP3888,0.013441314650369438,1.3692890177372596,5.9008443987208405,"['RPL5', 'ARF4', 'ITGB5', 'TRAF3IP2', 'LDB2', 'SLC8A1', 'RPL7', 'HERPUD1', 'RND1', 'PPP3CA', 'RPL18A', 'TMSB4X', 'RACK1', 'RPLP2', 'ELOC', 'RAC1', 'ATP6V1E1', 'ADAMTS9', 'HRAS', 'PRKG1', 'TMOD1', 'MAP2K4', 'MAP2K1', 'PRKCE', 'RPS6', 'RPL13A', 'ADAM10', 'SND1', 'RCN1', 'KATNAL2', 'NCL', 'NUMB', 'MYH9', 'RPL27', 'RPL26', 'PFN1', 'ATP6V0D1', 'PTMA', 'ATF4', 'LRRC59', 'ROCK2', 'TXN', 'ACACB', 'ACACA', 'LDHA', 'RAP1A', 'FAM120A', 'PGK1', 'ABL1', 'DNAJB9', 'PTK2B', 'RICTOR', 'FYN', 'PLCG1', 'CCT7', 'ABCF2', 'MAP2K6', 'CREBBP', 'JUN', 'FN1', 'PRRC2C', 'PDE4DIP', 'PTK2', 'RAB11A', 'VEGFA', 'PPP1CA', 'DNAJA1', 'RPS6KB1', 'SPIRE1', 'PTPN9', 'CYCS', 'P4HB', 'EIF3F']",0.40465130774276853,0,0,73
18,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.013873759122609207,4.195742813254334,17.948364228623003,"['MAG', 'OMG', 'PLP1', 'MBP', 'ASCL1', 'SOX5']",0.40465130774276853,0,0,6
19,Glycolysis in senescence WP5049,0.016744172970829304,4.893551688843398,20.013182631372246,"['RB1', 'LDHA', 'PKM', 'PGK1', 'ALDOC']",0.4126684560298587,0,0,5
20,Robo4 and VEGF Signaling Pathways Crosstalk WP3943,0.017117131919478987,14.671779141104295,59.68003582553162,"['SLIT2', 'RAC1', 'VEGFA']",0.4126684560298587,0,0,3
21,Type 2 papillary renal cell carcinoma WP4241,0.017418118750204038,2.5783802759849856,10.44307003425229,"['EGLN1', 'SETD2', 'EGLN3', 'CREBBP', 'TGFB1', 'CADM2', 'EP300', 'ELOB', 'ELOC', 'VEGFA']",0.4126684560298587,0,0,10
22,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.017463044522964526,2.144762210796915,8.681286167106745,"['GRIA1', 'MAP2K4', 'MAP2K1', 'JUN', 'ROCK2', 'FN1', 'PTK2', 'MYLK', 'SOD1', 'APC', 'TMSB4X', 'PLCG1', 'PFN1', 'PFN2']",0.4126684560298587,0,0,14
23,15q13.3 copy number variation syndrome WP4942,0.01886484370422211,6.522762148337596,25.898334959114337,"['KAT2B', 'CREBBP', 'OTUD7A', 'FYN']",0.4126684560298587,0,0,4
24,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.01886484370422211,6.522762148337596,25.898334959114337,"['NSDHL', 'EBP', 'CYP51A1', 'DHCR24']",0.4126684560298587,0,0,4
25,Intraflagellar transport proteins binding to dynein WP4532,0.02301350619170632,2.5927601809954752,9.779046187983953,"['IFT22', 'DYNC1LI2', 'DYNLT1', 'WDR60', 'DYNLT3', 'WDR19', 'IFT27', 'DYNLL2', 'DYNC1I1']",0.48328363002583274,0,0,9
26,3q29 copy number variation syndrome WP4906,0.025250904365690517,2.018176319370936,7.424655354565956,"['GRIA1', 'JUN', 'TGFB1', 'DYNLT1', 'DYNLT3', 'CEP350', 'MYCBP2', 'ADAM10', 'FBXO45', 'DYNLL2', 'DLG1', 'TF', 'BRINP1', 'WDR60']",0.5098740304610585,0,0,14
27,Secretion of Hydrochloric Acid in Parietal Cells WP2597,0.028875198073893018,inf,inf,"['CHRM1', 'HRH2']",0.5399880810466179,0,0,2
28,Exercise-induced Circadian Regulation WP410,0.0298068044872877,2.099713845476557,7.37633373722095,"['DNAJA1', 'IDI1', 'DAZAP2', 'PURA', 'HSPA8', 'PER1', 'CEBPB', 'SUMO1', 'ERC2', 'AZIN1', 'HERPUD1', 'ETV6']",0.5399880810466179,0,0,12
29,Androgen receptor signaling pathway WP138,0.03015622184337987,1.7209087701202466,6.025528039307223,"['RB1', 'CREBBP', 'JUN', 'ROCK2', 'NCOA3', 'DSTN', 'UBE3A', 'PARK7', 'PIAS2', 'PTK2', 'PIAS1', 'KAT2B', 'SUMO1', 'KAT5', 'BAG1', 'RACK1', 'EP300', 'RAC1', 'FKBP4', 'RAN']",0.5399880810466179,0,0,20
30,PKC-gamma calcium signaling pathway in ataxia WP4760,0.030856461774092448,2.855404713114754,9.93226571753037,"['GRIA1', 'PLCB4', 'GNAQ', 'ITPR1', 'ATP2B2', 'CA8', 'GRIA4']",0.5399880810466179,0,0,7
31,miR-509-3p alteration of YAP1/ECM axis WP3967,0.03271101312673085,4.89156010230179,16.729348161113883,"['SPARC', 'PBX3', 'FN1', 'GPC6']",0.5539768352107644,0,0,4
32,Myometrial relaxation and contraction pathways WP289,0.03719003203681831,1.5558401574703797,5.121381620977861,"['ATF1', 'RYR1', 'ATF6B', 'YWHAB', 'ITPR1', 'ADCY2', 'ADCY8', 'SLC8A1', 'RGS2', 'GRK5', 'PRKAR2A', 'PLCG1', 'RGS9', 'CORIN', 'RGS7', 'JUN', 'GSTO1', 'PRKCE', 'CREB3', 'ADCY9', 'PRKAR1A', 'GNB2', 'GNAQ', 'CALM3', 'CALM1', 'ATF4']",0.5949612115913896,0,0,26
33,Farnesoid X receptor pathway WP2879,0.037397561871458776,7.335122699386503,24.104311751627836,"['PPARGC1A', 'SLC27A5', 'FKBP5']",0.5949612115913896,0,0,3
34,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.03915097916787115,3.4946629624214065,11.323860699489604,"['CD63', 'CD81', 'SPP1', 'SORBS2', 'SOD1']",0.6045371783274222,0,0,5
35,TGF-beta Receptor Signaling WP560,0.04242997722552215,2.129073995583019,6.727661251890086,"['SMAD2', 'ZEB2', 'CREBBP', 'JUN', 'TGFB1', 'ZFYVE9', 'NOG', 'SPP1', 'EP300', 'HRAS']",0.6364496583828323,0,0,10
36,Biomarkers for pyrimidine metabolism disorders WP4584,0.05110463178886009,3.912838874680307,11.63631383694201,"['NT5C', 'RRM2B', 'DPYD', 'CKB']",0.7084138560768752,0,0,4
37,Biotin Metabolism (including IEMs) WP5031,0.05110463178886009,3.912838874680307,11.63631383694201,"['PCCA', 'HLCS', 'ACACB', 'ACACA']",0.7084138560768752,0,0,4
38,Glycogen Synthesis and Degradation WP500,0.051275669582707156,2.0401487942534633,6.060341388679683,"['GSK3A', 'PPP2R5E', 'PPP2R2B', 'PPP2R5B', 'PHKA1', 'PHKB', 'CALM3', 'CALM1', 'GYG1', 'PHKA2']",0.7084138560768752,0,0,10
39,Circadian rhythm related genes WP3594,0.05365453520786195,1.4431433537645229,4.221467468291414,"['CHRM1', 'ROCK2', 'BHLHE41', 'UBE3A', 'RORA', 'RORB', 'HEBP1', 'PPP1CC', 'NRIP1', 'EP300', 'BTRC', 'PPARGC1A', 'SKP1', 'CHRNB2', 'JUN', 'HOMER1', 'KCND2', 'NTRK3', 'DYRK1A', 'BTBD9', 'PPP1CA', 'PER1', 'PSPC1', 'ID2', 'GNAQ', 'KCNMA1', 'PPARG', 'PPARA', 'UBA52', 'ATF4']",0.7222725893366032,0,0,30
40,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.05555684080212384,1.9237496333235553,5.560307105069236,"['RB1', 'SMAD2', 'KAT2B', 'CEBPB', 'CREBBP', 'TLE1', 'TGFB1', 'APC', 'SPP1', 'PPARG', 'DICER1']",0.7291835355278754,0,0,11
41,TGF-beta Signaling Pathway WP366,0.06148385501128115,1.5035537190082644,4.193382241744592,"['MEF2A', 'SMAD2', 'MAP2K4', 'MAP2K1', 'CREBBP', 'JUN', 'TGFB1', 'SMURF2', 'ZFYVE9', 'FN1', 'PIAS2', 'PTK2', 'PIAS1', 'ZEB2', 'ZFYVE16', 'ZEB1', 'SUMO1', 'PRKAR2A', 'EP300', 'RAC1', 'BTRC', 'SKP1', 'MAP2K6']",0.7872932653883561,0,0,23
42,Regulation of Microtubule Cytoskeleton WP2038,0.06532410206848492,1.8572187212348652,5.067224811799336,"['TRIO', 'APC', 'CFL2', 'DPYSL2', 'TAOK1', 'GNAQ', 'STMN1', 'ABL1', 'RAC1', 'MARK2', 'MARK1']",0.7907797775444845,0,0,11
43,Cellular Proteostasis WP4918,0.06545973263225527,4.889570552147239,13.330534449120023,"['VBP1', 'PFDN4', 'PFDN5']",0.7907797775444845,0,0,3
44,Netrin-UNC5B signaling pathway WP4747,0.0675036284345016,2.0024475524475522,5.3977454144912835,"['MAP2K1', 'JUN', 'DAPK1', 'PTK2B', 'FYN', 'RAC1', 'NEO1', 'PTK2', 'PPP1CA']",0.7907797775444845,0,0,9
45,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.07054303311600389,2.446236559139785,6.486275388390761,"['PPP3CA', 'GSK3A', 'DYRK1A', 'FYN', 'PLCG1', 'CALM1']",0.7907797775444845,0,0,6
46,Proximal tubule transport WP4917,0.07425859503043583,2.0605897110793387,5.357948972807483,"['ATP6V0B', 'SLC20A2', 'CA4', 'ATP6V1E1', 'ATP1B1', 'ATP6V0C', 'ATP6V1D', 'ATP6V1F']",0.7907797775444845,0,0,8
47,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.0768186069614642,9.776188042922842,25.088713397054622,"['PPARG', 'PPARA']",0.7907797775444845,0,0,2
48,FTO Obesity Variant Mechanism WP3407,0.0768186069614642,9.776188042922842,25.088713397054622,"['ARID5B', 'PPARGC1A']",0.7907797775444845,0,0,2
49,Gene regulatory network modelling somitogenesis  WP2854,0.0768186069614642,9.776188042922842,25.088713397054622,"['EPHA4', 'RIPPLY2']",0.7907797775444845,0,0,2
50,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.0768186069614642,9.776188042922842,25.088713397054622,"['NKRF', 'FYN']",0.7907797775444845,0,0,2
51,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.0768186069614642,9.776188042922842,25.088713397054622,"['EPHA4', 'RIPPLY2']",0.7907797775444845,0,0,2
52,Aryl Hydrocarbon Receptor Netpath WP2586,0.08034648774335112,1.9151839464882943,4.828958016912895,"['RB1', 'MAP2K1', 'CDC37', 'NRIP1', 'AIP', 'NF1', 'EP300', 'HRAS', 'VEGFA']",0.8068353751472672,0,0,9
53,Sphingolipid pathway WP1422,0.08145195215772412,2.140657018442623,5.3682154627841845,"['SGPL1', 'CERS5', 'CERS6', 'SGMS1', 'GBA', 'SERINC1', 'PPP1CA']",0.8068353751472672,0,0,7
54,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.08479628020369216,1.8128955019668207,4.473326182365371,"['SMAD2', 'ZEB2', 'CREBBP', 'JUN', 'TGFB1', 'ZFYVE9', 'NOG', 'SPP1', 'EP300', 'HRAS']",0.8244082797581181,0,0,10
55,Hippo-Merlin Signaling Dysregulation WP4541,0.09304082651372368,1.4944594346789615,3.5489180570479633,"['PPP1R14A', 'PPP1R12A', 'ITGB5', 'ITGAE', 'PTK2', 'IGF1R', 'PPP1CA', 'LATS1', 'DDB1', 'PPP1CC', 'PLCB4', 'CDH2', 'PRKAR1A', 'PRKAR2A', 'CDH13', 'HRAS', 'FGFR2', 'PAK5']",0.8835011291822477,0,0,18
56,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.09886212323304507,2.0145250723240116,4.661669628280124,"['EGLN1', 'LDHA', 'PDHA1', 'PKM', 'ANGPT1', 'PGK1', 'VEGFA']",0.8835011291822477,0,0,7
57,Dual hijack model of Vif in HIV infection WP3300,0.10040593081348488,3.666794478527607,8.428251785854496,"['UBB', 'ELOB', 'ELOC']",0.8835011291822477,0,0,3
58,Glial Cell Differentiation WP2276,0.10040593081348488,3.666794478527607,8.428251785854496,"['MAG', 'PLP1', 'MBP']",0.8835011291822477,0,0,3
59,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.10118052384379395,2.794300328827183,6.401320093836694,"['RYR1', 'GNAQ', 'ITPR1', 'CCK']",0.8835011291822477,0,0,4
60,Cori Cycle WP1946,0.10118052384379395,2.794300328827183,6.401320093836694,"['LDHA', 'PGAM1', 'PGK1', 'PFKP']",0.8835011291822477,0,0,4
61,Pathways affected in adenoid cystic carcinoma WP3651,0.10265441691450879,1.6317411402157165,3.714474494467429,"['SETD2', 'CREBBP', 'MYCBP', 'NFIB', 'NSD1', 'JMJD1C', 'EP300', 'TLK1', 'ARID5B', 'ARID4B', 'MAML3', 'HRAS']",0.8835011291822477,0,0,12
62,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.10832458460096282,1.27521875,2.834330710104926,"['LAMA5', 'CHRM1', 'ITGB5', 'ATF6B', 'ITGAE', 'EFNA5', 'ACACA', 'IGF1R', 'RPTOR', 'GNG10', 'PPP2R5E', 'PPP2R3C', 'PDGFC', 'SPP1', 'PPARGC1A', 'HRAS', 'MAP2K1', 'ANGPT1', 'RPS6', 'FN1', 'VEGFB', 'PPP2R5B', 'VEGFD', 'PTK2', 'VEGFA', 'CREB3', 'FGF14', 'COL4A2', 'PIK3IP1', 'RPS6KB1', 'PPP2R2B', 'CDC37', 'GNB2', 'COL5A2', 'IL3RA', 'PPP2R2D', 'FGF12', 'FGFR2', 'ATF4']",0.9099306971660166,0,0,39
63,Physiological and pathological hypertrophy of the heart WP1528,0.10949949208955158,2.096335308316875,4.636748578516398,"['PPP3CA', 'JUN', 'PRKCE', 'LIFR', 'RAC1', 'CALM1']",0.9099306971660166,0,0,6
64,IL-18 signaling pathway WP4754,0.11092488498785726,1.3073170731707318,2.874662151097914,"['CEBPB', 'STOML1', 'CD81', 'TSHZ1', 'HSPB8', 'COX17', 'PLD1', 'ACACB', 'CENPB', 'RPTOR', 'RXRB', 'TMSB4X', 'STMN1', 'SPP1', 'TIMP3', 'PLCG1', 'LRRFIP1', 'B2M', 'ZBTB7A', 'MEF2A', 'JUN', 'TICAM2', 'FN1', 'TACR1', 'BPGM', 'EEF2', 'VEGFA', 'ARFGAP2', 'TF', 'RPS6KB1', 'NACA', 'CYCS']",0.9099306971660166,0,0,32
65,Ciliopathies WP4803,0.12361333012481965,1.3011464512310933,2.720172725507023,"['IFT172', 'ARL3', 'CEP120', 'TBC1D32', 'CSPP1', 'TTC21B', 'SUFU', 'NEK1', 'CEP290', 'DNAI1', 'CEP78', 'BBS2', 'TUB', 'WDR19', 'LCA5', 'SCLT1', 'RPGRIP1L', 'TMEM231', 'AHI1', 'TTLL5', 'WDR60', 'TMEM237', 'KIAA0586', 'MAK', 'NME9', 'SPAG1', 'IFT27', 'CCDC65', 'KIZ', 'TRIM32']",0.9242929887498897,0,0,30
66,Ferroptosis WP4313,0.12364460420785393,1.77904105120917,3.718807651212901,"['PRNP', 'TF', 'GPX4', 'VDAC3', 'VDAC2', 'SAT2', 'ACSL3', 'FTL']",0.9242929887498897,0,0,8
67,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.12988007180008018,1.5150124798120688,3.0923582981682642,"['RB1', 'MAP2K1', 'JUN', 'RPS6', 'ADCY2', 'PLD1', 'IGF1R', 'MYL12B', 'RAP1A', 'RPS6KB1', 'GNAQ', 'HRAS', 'MAP2K6']",0.9242929887498897,0,0,13
68,miRNA targets in ECM and membrane receptors WP2911,0.13219531141234814,2.4447570332480817,4.946904293054378,"['ITGB5', 'COL4A2', 'COL5A2', 'FN1']",0.9242929887498897,0,0,4
69,Nanomaterial induced apoptosis WP2507,0.13219531141234814,2.4447570332480817,4.946904293054378,"['ENDOG', 'CASP6', 'HTRA2', 'CYCS']",0.9242929887498897,0,0,4
70,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.13219531141234814,2.4447570332480817,4.946904293054378,"['SMAD2', 'TGFB1', 'CDH2', 'FN1']",0.9242929887498897,0,0,4
71,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.13467672620738785,1.3131663297795746,2.6327382756174917,"['GRIA1', 'DOCK3', 'ACACB', 'RAP1A', 'CDH2', 'DPYSL2', 'NCK2', 'RACK1', 'SPP1', 'PTK2B', 'FYN', 'PLCG1', 'RAC1', 'HRAS', 'MEF2A', 'NSF', 'VAV3', 'MAP2K1', 'JUN', 'NTRK3', 'RPS6', 'EEF2', 'DLG1', 'RPS6KB1', 'APC', 'CDK5R1']",0.9242929887498897,0,0,26
72,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.13604467547829688,1.346889519876097,2.6867374353786224,"['CHRNB2', 'DLX2', 'CREBBP', 'JUN', 'CEBPB', 'VIPR2', 'YWHAB', 'AQP4', 'RORA', 'TACR1', 'ASCL1', 'VEGFA', 'TF', 'PRKAR1A', 'MAP2', 'PRKAR2A', 'SP3', 'PLP1', 'EP300', 'PPARGC1A', 'SLC25A4', 'CC2D1A']",0.9242929887498897,0,0,22
73,Blood Clotting Cascade WP272,0.13652012905756047,4.887583035258048,9.732562033664262,"['PLAT', 'KLKB1']",0.9242929887498897,0,0,2
74,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.13652012905756047,4.887583035258048,9.732562033664262,"['NRIP1', 'FN1']",0.9242929887498897,0,0,2
75,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.13652012905756047,4.887583035258048,9.732562033664262,"['VEGFB', 'VEGFA']",0.9242929887498897,0,0,2
76,Complement system WP2806,0.13919236093629136,1.8020923209663502,3.5535429840427497,"['PRNP', 'LAMA5', 'RPS19', 'SPP1', 'CD59', 'TXN', 'KLKB1']",0.9242929887498897,0,0,7
77,Fragile X Syndrome  WP4549,0.14055515432848972,1.3208605522167058,2.591733545959076,"['GRIA1', 'EPHA4', 'GABRB2', 'MAP2K1', 'DUSP3', 'HOMER1', 'KCND2', 'ITPR1', 'PPP2R5B', 'DICER1', 'DNM2', 'PPP1CA', 'EEF1A1', 'RPTOR', 'ARHGAP32', 'PPP3CA', 'GRM5', 'RPS6KB1', 'PRKAR1A', 'NF1', 'FYN', 'PLCG1', 'GABRD', 'AP2M1']",0.9242929887498897,0,0,24
78,Galanin receptor pathway WP4970,0.14102290342959295,2.9331288343558284,5.745509454626061,"['PPARG', 'PPARGC1A', 'VEGFA']",0.9242929887498897,0,0,3
79,Matrix Metalloproteinases WP129,0.14102290342959295,2.9331288343558284,5.745509454626061,"['MMP16', 'TIMP2', 'TIMP3']",0.9242929887498897,0,0,3
80,Vitamin D-sensitive calcium signaling in depression WP4698,0.14317190548682707,1.7015131593608628,3.3072468403674162,"['GRM5', 'CHRM1', 'GPX4', 'ITPR1', 'KCNQ3', 'ATP2B2', 'CACNA1C', 'SLC8A1']",0.9242929887498897,0,0,8
81,Spinal Cord Injury WP2431,0.14425936266603898,1.4796242740027248,2.8647633963469366,"['RB1', 'EPHA4', 'TGFB1', 'ROCK2', 'OMG', 'AQP4', 'TACR1', 'RTN4', 'PPP3CA', 'MAG', 'MBP', 'RAC1', 'SLIT2']",0.9242929887498897,0,0,13
82,Translation Factors WP107,0.1460811619917177,1.5378703432091523,2.9582364851260077,"['EIF4A2', 'EEF1B2', 'EEF1G', 'EEF1A1', 'EIF5', 'EIF6', 'EIF1AX', 'EIF3I', 'EIF4H', 'EIF3F', 'EEF2']",0.9242929887498897,0,0,11
83,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.14612632012617305,1.5783114583160927,3.035540898600034,"['PPP1R15A', 'PPP1R16B', 'PPP1CC', 'PPP1R14A', 'PPP1R14B', 'PPP1R13B', 'PPP1R12A', 'PPP1R9A', 'PPP1CA', 'ATF4']",0.9242929887498897,0,0,10
84,G Protein Signaling Pathways WP35,0.1495726621986787,1.3870494335736354,2.6353564310867603,"['PRKCE', 'ITPR1', 'ADCY2', 'ADCY8', 'AKAP13', 'PPP3CA', 'GNG10', 'ADCY9', 'GNAL', 'PRKAR1A', 'PRKAR2A', 'GNB2', 'GNAQ', 'AKAP9', 'PDE7A', 'CALM1', 'HRAS']",0.9348291387417419,0,0,17
85,Calcium Regulation in the Cardiac Cell WP536,0.1542276283342751,1.30971915241207,2.448291621387959,"['RYR1', 'CHRM1', 'YWHAB', 'PRKCE', 'CACNA1B', 'ITPR1', 'ADCY2', 'ATP2B2', 'CACNA1C', 'ATP1B1', 'ADCY8', 'SLC8A1', 'RGS2', 'ADCY9', 'GRK5', 'PRKAR1A', 'PRKAR2A', 'GNB2', 'GNAQ', 'CALM3', 'CALM1', 'RGS9', 'RGS7']",0.9447596004070697,0,0,23
86,TNF-alpha signaling pathway WP231,0.1547606202571581,1.4118886514719848,2.6344087841885284,"['MAP2K4', 'CREBBP', 'JUN', 'OTUD7B', 'KSR2', 'TXN', 'TANK', 'PSMD2', 'CDC37', 'RAC1', 'BTRC', 'GLUL', 'HRAS', 'SKP1', 'MAP2K6']",0.9447596004070697,0,0,15
87,Common Pathways Underlying Drug Addiction WP2636,0.1647258297197211,1.5723626373626374,2.8357132878363527,"['GRIA1', 'PPP1CC', 'GRM5', 'MAP2K1', 'RAP1A', 'ADCY8', 'CALM1', 'GRIA4', 'PPP1CA']",0.9894960016567331,0,0,9
88,White fat cell differentiation WP4149,0.17841969839590982,1.880560585780647,3.2413655330630036,"['TLE3', 'CEBPB', 'RORA', 'PPARG', 'NR2F2']",0.9894960016567331,0,0,5
89,Glucocorticoid Receptor Pathway WP2880,0.18532134324059735,1.5179840848806365,2.558811079277138,"['EPB41L4B', 'AKAP13', 'FGD4', 'RGS2', 'JUN', 'NAV3', 'ABHD2', 'LRRC8A', 'MFGE8']",0.9894960016567331,0,0,9
90,Development and heterogeneity of the ILC family WP3893,0.18598205228485057,2.4440184049079754,4.111095830762917,"['ID2', 'RORA', 'TOX']",0.9894960016567331,0,0,3
91,Hypertrophy Model WP516,0.18598205228485057,2.4440184049079754,4.111095830762917,"['ZEB1', 'ADAM10', 'VEGFA']",0.9894960016567331,0,0,3
92,Major receptors targeted by epinephrine and norepinephrine WP4589,0.18598205228485057,2.4440184049079754,4.111095830762917,"['ADCY9', 'ADCY2', 'ADCY8']",0.9894960016567331,0,0,3
93,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.18598205228485057,2.4440184049079754,4.111095830762917,"['JUN', 'PLCG1', 'PTK2']",0.9894960016567331,0,0,3
94,Pyrimidine metabolism and related diseases WP4225,0.18598205228485057,2.4440184049079754,4.111095830762917,"['NT5C', 'RRM2B', 'DPYD']",0.9894960016567331,0,0,3
95,Alzheimer's disease WP2059,0.1921697459223897,1.382691362438,2.2805782309427785,"['ATP5MD', 'ITPR1', 'ADAM10', 'IDE', 'CACNA1C', 'PPP3CA', 'PLCB4', 'GNAQ', 'CYCS', 'CALM3', 'APOE', 'CALM1', 'CDK5R1']",0.9894960016567331,0,0,13
96,Dopaminergic Neurogenesis WP2855,0.2026018611517286,3.258048032703117,5.201514412656764,"['TGFB1', 'ASCL1']",0.9894960016567331,0,0,2
97,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.2026018611517286,3.258048032703117,5.201514412656764,"['CEBPB', 'ALDH1L1']",0.9894960016567331,0,0,2
98,Inflammatory Response Pathway WP453,0.2026018611517286,3.258048032703117,5.201514412656764,"['LAMA5', 'FN1']",0.9894960016567331,0,0,2
99,miRNA Biogenesis WP2338,0.2026018611517286,3.258048032703117,5.201514412656764,"['DICER1', 'RAN']",0.9894960016567331,0,0,2
100,Mitochondrial fatty acid synthesis pathway WP4317,0.2026018611517286,3.258048032703117,5.201514412656764,"['MCAT', 'ACACA']",0.9894960016567331,0,0,2
101,Pregnane X receptor pathway WP2876,0.20357926020361303,1.95539641943734,3.1124042166425068,"['PSMC5', 'NCOA3', 'NRIP1', 'PPARGC1A']",0.9894960016567331,0,0,4
102,Transcription co-factors SKI and SKIL protein partners WP4533,0.20357926020361303,1.95539641943734,3.1124042166425068,"['LATS1', 'SATB2', 'NF1', 'MERTK']",0.9894960016567331,0,0,4
103,Transcription factor regulation in adipogenesis WP3599,0.20357926020361303,1.95539641943734,3.1124042166425068,"['CEBPB', 'NRIP1', 'PPARG', 'PPARGC1A']",0.9894960016567331,0,0,4
104,Vitamin B12 metabolism WP1533,0.20357926020361303,1.95539641943734,3.1124042166425068,"['CUBN', 'PLAT', 'APOE', 'SOD1']",0.9894960016567331,0,0,4
105,Cardiac Hypertrophic Response WP2795,0.20362608579899003,1.4385959617299973,2.2894821421915807,"['MEF2A', 'PPP3CA', 'MAP2K4', 'MAP2K1', 'TGFB1', 'RAC1', 'CALM1', 'PRKG1', 'FGFR2', 'MAP2K6']",0.9894960016567331,0,0,10
106,Interferon type I signaling pathways WP585,0.20362608579899003,1.4385959617299973,2.2894821421915807,"['RPTOR', 'RAP1A', 'RPS6KB1', 'PRMT1', 'RPS6', 'RACK1', 'FYN', 'RAC1', 'PIAS1', 'MAP2K6']",0.9894960016567331,0,0,10
107,Leptin signaling pathway WP2034,0.20469538539412074,1.3430515650990473,2.130391813191198,"['GSK3A', 'MAP2K1', 'ROCK2', 'RPS6', 'ACACB', 'ACACA', 'PTK2', 'RPS6KB1', 'CFL2', 'LEPR', 'FYN', 'RAC1', 'PLCG1', 'HRAS']",0.9894960016567331,0,0,14
108,Histone Modifications WP2369,0.20698081776674854,1.4672307692307693,2.3110779658428386,"['KMT2E', 'SETD5', 'SETD2', 'NSD1', 'H3F3A', 'EHMT1', 'ASH1L', 'SMYD3', 'HIST1H4C']",0.9894960016567331,0,0,9
109,The influence of laminopathies on Wnt signaling WP4844,0.2123745497864285,1.629800307219662,2.525218820036503,"['CEBPB', 'TLE1', 'APC', 'SPP1', 'PPARG', 'DICER1']",0.9894960016567331,0,0,6
110,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.21459755951396628,1.3651055290787257,2.100884879092826,"['PRKN', 'HSPA8', 'TUBB2B', 'PSMC5', 'TUBA1A', 'PSMD7', 'PSMC6', 'PSMD14', 'PSMD2', 'RNF19A', 'UBE2G1', 'SNCAIP']",0.9894960016567331,0,0,12
111,Joubert Syndrome WP4656,0.22183052093887692,1.3170852283962824,1.9833217380128736,"['BBS2', 'CETN2', 'ARL3', 'CEP120', 'RPGRIP1L', 'TMEM231', 'AHI1', 'KAT5', 'KIAA0586', 'TMEM237', 'SUFU', 'CSPP1', 'CEP290', 'ATF4']",0.9894960016567331,0,0,14
112,Computational Model of Aerobic Glycolysis WP4629,0.23396938204513126,2.0946538124452236,3.042620853085116,"['LDHA', 'PKM', 'PGK1']",0.9894960016567331,0,0,3
113,Differentiation of white and brown adipocyte WP2895,0.23396938204513126,2.0946538124452236,3.042620853085116,"['CEBPB', 'PPARG', 'PPARGC1A']",0.9894960016567331,0,0,3
114,Fatty acid transporters WP5061,0.23396938204513126,2.0946538124452236,3.042620853085116,"['FABP3', 'FABP5', 'ACSL3']",0.9894960016567331,0,0,3
115,Interleukin-11 Signaling Pathway WP2332,0.2343402441421395,1.448829660003417,2.1022245768102508,"['ATF1', 'MAP2K1', 'TGFB1', 'RPS6KB1', 'RPS6', 'FYN', 'HRAS', 'PIAS1']",0.9894960016567331,0,0,8
116,IL-2 signaling pathway WP49,0.23864768945053277,1.4880612972202423,2.1320449976109503,"['MAP2K1', 'JUN', 'RPS6KB1', 'RPS6', 'PTK2B', 'FYN', 'HRAS']",0.9894960016567331,0,0,7
117,MAPK Cascade WP422,0.23864768945053277,1.4880612972202423,2.1320449976109503,"['MAP2K4', 'MAP2K1', 'JUN', 'MAP2', 'MBP', 'HRAS', 'MAP2K6']",0.9894960016567331,0,0,7
118,Integrated breast cancer pathway WP1984,0.24018826071589383,1.2102439349506797,1.7262099469046022,"['ATF1', 'RB1', 'SMAD2', 'JUN', 'GSK3A', 'USP15', 'RALGAPA1', 'NCOA3', 'MYCBP2', 'ODC1', 'PPP4R3B', 'PHB', 'JAKMIP1', 'PIAS1', 'VEGFA', 'FER', 'RAP1A', 'ABL1', 'NF1', 'EP300', 'RAC1', 'FAU', 'RPP38']",0.9894960016567331,0,0,23
119,PI3K-Akt signaling pathway WP4172,0.2403537015976295,1.159577962065851,1.6531449976052153,"['LAMA5', 'CHRM1', 'ITGB5', 'ATF6B', 'EFNA5', 'IGF1R', 'RPTOR', 'GNG10', 'PPP2R5E', 'PPP2R3C', 'PDGFC', 'SPP1', 'RAC1', 'HRAS', 'MAP2K1', 'ANGPT1', 'RPS6', 'FN1', 'VEGFB', 'PPP2R5B', 'VEGFD', 'PTK2', 'VEGFA', 'CREB3', 'FGF14', 'COL4A2', 'RPS6KB1', 'PPP2R2B', 'CDC37', 'GNB2', 'IL3RA', 'PPP2R2D', 'SGK1', 'FGF12', 'FGFR2', 'ATF4']",0.9894960016567331,0,0,36
120,Cholesterol Biosynthesis Pathway WP197,0.24272838796795798,1.7774471053243432,2.5165313068327086,"['IDI1', 'NSDHL', 'CYP51A1', 'PMVK']",0.9894960016567331,0,0,4
121,Mitochondrial complex III assembly WP4921,0.24272838796795798,1.7774471053243432,2.5165313068327086,"['UQCRB', 'UQCC3', 'UQCR11', 'UQCRH']",0.9894960016567331,0,0,4
122,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.24272838796795798,1.7774471053243432,2.5165313068327086,"['EIF5', 'EIF1AX', 'EIF3I', 'EIF3F']",0.9894960016567331,0,0,4
123,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.24404061770437913,1.6294779938587514,2.298249332296585,"['SMAD2', 'TGFB1', 'APC', 'MFGE8', 'HRAS']",0.9894960016567331,0,0,5
124,Genes controlling nephrogenesis WP4823,0.24404061770437913,1.6294779938587514,2.298249332296585,"['NCK2', 'SLIT2', 'ETV4', 'FGFR2', 'VEGFA']",0.9894960016567331,0,0,5
125,Synaptic Vesicle Pathway WP2267,0.24648480337765907,1.358388917393535,1.9023624657072293,"['NSF', 'RIMS1', 'UNC13C', 'CACNA1B', 'SLC17A7', 'PARK7', 'SYN3', 'SLC25A4', 'AP2M1', 'DNM2']",0.9894960016567331,0,0,10
126,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.25308225349418806,1.3752403846153847,1.8896363026446759,"['SMAD2', 'MAP2K1', 'TGFB1', 'ADCY9', 'ADCY2', 'MAP3K9', 'ADCY8', 'HRAS', 'PLEC']",0.9894960016567331,0,0,9
127,EGF/EGFR signaling pathway WP437,0.25937910214256304,1.1780479392998793,1.5897339589483073,"['ATF1', 'NDUFA13', 'PEBP1', 'NEDD8', 'ASAP1', 'PLD1', 'ATXN2', 'RAP1A', 'RPS6KA2', 'STMN1', 'ABL1', 'NCK2', 'PLCE1', 'PTK2B', 'RICTOR', 'PLCG1', 'RAC1', 'HRAS', 'AP2M1', 'MEF2A', 'VAV3', 'MAP2K1', 'JUN', 'NCOA3', 'PTK2', 'RPS6KB1']",0.9894960016567331,0,0,26
128,Focal Adhesion WP306,0.25937910214256304,1.1780479392998793,1.5897339589483073,"['LAMA5', 'ITGB5', 'ROCK2', 'MYLK', 'MYL12B', 'IGF1R', 'PPP1CC', 'RAP1A', 'PDGFC', 'SPP1', 'FYN', 'RAC1', 'HRAS', 'VAV3', 'JUN', 'MAP2K1', 'PPP1R12A', 'FN1', 'VEGFB', 'PARVA', 'VEGFD', 'PTK2', 'VEGFA', 'PPP1CA', 'COL4A2', 'COL5A2']",0.9894960016567331,0,0,26
129,Metabolic reprogramming in colon cancer WP4290,0.25978502608195414,1.3969392985282272,1.8829356158273733,"['ACLY', 'LDHA', 'PDHA1', 'PKM', 'MDH2', 'PGAM1', 'PGK1', 'PDHB']",0.9894960016567331,0,0,8
130,Pathogenic Escherichia coli infection WP2272,0.25978502608195414,1.3969392985282272,1.8829356158273733,"['TUBB2B', 'TUBA1A', 'ROCK2', 'NCL', 'NCK2', 'ABL1', 'FYN', 'ARPC4']",0.9894960016567331,0,0,8
131,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.2664947918336229,1.4259093237704918,1.8856233145077363,"['RPTOR', 'SMAD2', 'RPS6KB1', 'RICTOR', 'PLD1', 'PPARGC1A', 'IGF1R']",0.9894960016567331,0,0,7
132,Aspirin and miRNAs WP4707,0.2711729272964965,2.4432805314256516,3.188477559309322,"['PPARA', 'VEGFA']",0.9894960016567331,0,0,2
133,Insulin signaling in adipocytes (diabetic condition) WP3635,0.2711729272964965,2.4432805314256516,3.188477559309322,"['RPS6KB1', 'RPS6']",0.9894960016567331,0,0,2
134,Insulin signaling in adipocytes (normal condition) WP3634,0.2711729272964965,2.4432805314256516,3.188477559309322,"['RPS6KB1', 'RPS6']",0.9894960016567331,0,0,2
135,LDLRAD4 and what we know about it WP4904,0.2711729272964965,2.4432805314256516,3.188477559309322,"['SMAD2', 'LDLRAD4']",0.9894960016567331,0,0,2
136,Selective expression of chemokine receptors during T-cell polarization WP4494,0.2711729272964965,2.4432805314256516,3.188477559309322,"['TGFB1', 'IFNGR2']",0.9894960016567331,0,0,2
137,Transcriptional cascade regulating adipogenesis WP4211,0.2711729272964965,2.4432805314256516,3.188477559309322,"['CEBPB', 'PPARG']",0.9894960016567331,0,0,2
138,Senescence and Autophagy in Cancer WP615,0.27653178127850747,1.244851600841318,1.6001689998390356,"['RB1', 'GABARAPL2', 'MAP2K1', 'JUN', 'CEBPB', 'SPARC', 'TGFB1', 'FN1', 'PLAT', 'GABARAP', 'IGF1R', 'RSL1D1', 'LAMP1', 'HRAS']",0.9894960016567331,0,0,14
139,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.2772994115002727,1.3334265734265733,1.7103295265826952,"['IDI1', 'NSDHL', 'EBP', 'NR1H2', 'PMVK', 'CYP51A1', 'DHCR24', 'ACSL3', 'HSD17B7']",0.9894960016567331,0,0,9
140,Endochondral Ossification with Skeletal Dysplasias WP4808,0.2772994115002727,1.3334265734265733,1.7103295265826952,"['TGFB1', 'THRA', 'SPP1', 'TIMP3', 'PLAT', 'CALM1', 'IGF1R', 'SOX5', 'VEGFA']",0.9894960016567331,0,0,9
141,Endochondral Ossification WP474,0.2772994115002727,1.3334265734265733,1.7103295265826952,"['TGFB1', 'THRA', 'SPP1', 'TIMP3', 'PLAT', 'CALM1', 'IGF1R', 'SOX5', 'VEGFA']",0.9894960016567331,0,0,9
142,PPAR signaling pathway WP3942,0.28600825041719846,1.3486275826720162,1.6881238360199613,"['RXRB', 'FABP3', 'FABP5', 'PPARG', 'ACSL3', 'PPARA', 'RXRG', 'SLC27A5']",0.9894960016567331,0,0,8
143,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.3035750096828619,1.187648962777696,1.415827860780821,"['SMAD2', 'MAP2K4', 'MAP2K1', 'SPARC', 'TGFB1', 'WNT5B', 'TUSC3', 'FN1', 'TJP1', 'ZEB2', 'ZEB1', 'FMNL2', 'CDH2', 'COL4A2', 'ID2', 'HRAS', 'MAP2K6']",0.9894960016567331,0,0,17
144,Prion disease pathway WP3995,0.3047586614991127,1.3965328066710556,1.6594092843435604,"['PRNP', 'BCL11A', 'EP300', 'FYN', 'CHD2', 'PTK2']",0.9894960016567331,0,0,6
145,Composition of Lipid Particles WP3601,0.31105136180456644,4.885597548518897,5.705387283770556,['APOE'],0.9894960016567331,0,0,1
146,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.31105136180456644,4.885597548518897,5.705387283770556,['TGFB1'],0.9894960016567331,0,0,1
147,Gastric acid production WP2596,0.31105136180456644,4.885597548518897,5.705387283770556,['CCK'],0.9894960016567331,0,0,1
148,Steroid Biosynthesis WP496,0.31105136180456644,4.885597548518897,5.705387283770556,['HSD17B7'],0.9894960016567331,0,0,1
149,Splicing factor NOVA regulated synaptic proteins WP4148,0.3128580887778319,1.3035366478728856,1.5147168608318384,"['KCNJ6', 'PLCB4', 'CDH2', 'EPB41L2', 'KCNMA1', 'GRIK2', 'EFNA5', 'NEO1']",0.9894960016567331,0,0,8
150,Aryl Hydrocarbon Receptor Pathway WP2873,0.31473839850579716,1.4374736588596544,1.6617389068500985,"['JUN', 'TGFB1', 'CDC37', 'AIP', 'EP300']",0.9894960016567331,0,0,5
151,Photodynamic therapy-induced unfolded protein response WP3613,0.31473839850579716,1.4374736588596544,1.6617389068500985,"['PPP1R15A', 'DNAJB11', 'UBE2E1', 'DNAJB9', 'ATF4']",0.9894960016567331,0,0,5
152,Vitamin D Receptor Pathway WP2877,0.31619985395384803,1.2222650231124808,1.4072924997845122,"['TGFB1', 'CLMN', 'CREG2', 'NRIP1', 'S100A6', 'TIMP2', 'SPP1', 'TIMP3', 'CCNC', 'CDKAL1', 'EFNA5', 'SLC8A1']",0.9894960016567331,0,0,12
153,IL-3 signaling pathway WP286,0.32445170485015673,1.3159481399747792,1.4812556810720565,"['MAP2K1', 'JUN', 'TGFB1', 'YWHAB', 'IL3RA', 'FYN', 'HRAS']",0.9894960016567331,0,0,7
154,Differentiation Pathway WP2848,0.32486112780504367,1.5036789297658864,1.6906726627746325,"['TF', 'TGFB1', 'NOG', 'VEGFA']",0.9894960016567331,0,0,4
155,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.32486112780504367,1.5036789297658864,1.6906726627746325,"['ATF1', 'MAP2K1', 'RAP1A', 'HTR4']",0.9894960016567331,0,0,4
156,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.32746593778376903,1.256967032967033,1.4032418403090212,"['RXRB', 'IFI27L2', 'JUN', 'PLCB4', 'PRKCE', 'SP3', 'PLCE1', 'HRAS', 'RXRG']",0.9894960016567331,0,0,9
157,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.3342884900462557,1.6288343558282208,1.7847967376765468,"['TGFB1', 'CDC37', 'FN1']",0.9894960016567331,0,0,3
158,GABA receptor Signaling WP4159,0.33709852345361224,1.3329143974305264,1.449384506656224,"['GABRA2', 'GABRB2', 'GABRB1', 'GABRD', 'GABRG3', 'AP2M1']",0.9894960016567331,0,0,6
159,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.3394797144375344,1.9544200306591721,2.1114402565797077,"['SPP1', 'FGFR2']",0.9894960016567331,0,0,2
160,HIF1A and PPARG regulation of glycolysis WP2456,0.3394797144375344,1.9544200306591721,2.1114402565797077,"['LDHA', 'PPARG']",0.9894960016567331,0,0,2
161,Oncostatin M Signaling Pathway WP2374,0.33982436618779815,1.2220369420215496,1.3189766903764055,"['MAP2K1', 'CEBPB', 'PRKCE', 'RPS6', 'TIMP3', 'PTK2B', 'LIFR', 'RICTOR', 'HRAS', 'VEGFA']",0.9894960016567331,0,0,10
162,Male infertility WP4673,0.3470156541611563,1.1768585131894485,1.245569853157481,"['CREBBP', 'PACRG', 'CCNT2', 'PON2', 'DDX20', 'PEX10', 'CHD2', 'CDC42BPA', 'PUM2', 'ABLIM1', 'EP300', 'RGS9', 'SOX5']",0.9894960016567331,0,0,13
163,Pyrimidine metabolism WP4022,0.3470156541611563,1.1768585131894485,1.245569853157481,"['NME2', 'CTPS1', 'NT5C', 'POLE4', 'RRM2B', 'POLE2', 'POLR1C', 'DPYD', 'TWISTNB', 'POLD2', 'POLR3H', 'POLR2J', 'POLR2K']",0.9894960016567331,0,0,13
164,Adipogenesis WP236,0.35521109264030903,1.1599668859744674,1.2006156508814287,"['RB1', 'MEF2A', 'CEBPB', 'TGFB1', 'WNT5B', 'RORA', 'LIFR', 'KLF7', 'NRIP1', 'NDN', 'PPARG', 'PPARA', 'PPARGC1A', 'RXRG']",0.9894960016567331,0,0,14
165,Ciliary landscape WP4352,0.36115501229422886,1.0867532467532468,1.1068016879035323,"['RB1', 'DOCK5', 'IFT172', 'HTRA2', 'MYL6B', 'RPGR', 'PSMD7', 'CEP170', 'RAC1', 'CEP290', 'CDR2', 'BBS2', 'CREBBP', 'RNGTT', 'DYNLT1', 'DYNLT3', 'H3F3A', 'EXOC6B', 'LCA5', 'ACSL3', 'COX6C', 'DYNLL2', 'LSM4', 'IFT22', 'PSMC6', 'APC', 'WNK1', 'WDR60', 'GID8', 'EXOC4', 'CD2BP2', 'IFT27', 'CALM1', 'COPS8']",0.9894960016567331,0,0,34
166,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.3667015264214312,1.3961271465107783,1.400604583963752,"['MAP2K1', 'GNAQ', 'ITPR1', 'HRAS']",0.9894960016567331,0,0,4
167,Hepatitis B infection WP4666,0.36925063667967317,1.1190907961743883,1.114927368065702,"['SMAD2', 'MAP2K4', 'MAP2K1', 'CREBBP', 'JUN', 'TICAM2', 'TGFB1', 'ATF6B', 'YWHAB', 'TIRAP', 'DDB1', 'CREB3', 'VDAC3', 'EP300', 'CYCS', 'PTK2B', 'HRAS', 'ATF4', 'MAP2K6']",0.9894960016567331,0,0,19
168,Integrin-mediated Cell Adhesion WP185,0.37553120775525506,1.1405141388174806,1.1170351741570415,"['VAV3', 'MAP2K1', 'ITGB5', 'ROCK2', 'ITGAE', 'PTK2', 'RAP1A', 'CAPN10', 'SELENOP', 'FYN', 'RAC1', 'ARHGEF7', 'HRAS', 'MAP2K6']",0.9894960016567331,0,0,14
169,Mesodermal commitment pathway WP2857,0.37556871529332264,1.1229785398168508,1.0997484122904357,"['SMAD2', 'VAV3', 'MACF1', 'SETD2', 'NOG', 'PBX3', 'ARID5B', 'EMSY', 'ACACA', 'PIAS1', 'LATS1', 'CCDC88A', 'DDAH1', 'PRKAR1A', 'UBR5', 'RPL38', 'TOX']",0.9894960016567331,0,0,17
170,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.37911788095302246,1.1887733887733887,1.153000927805932,"['LAMA5', 'TGFB1', 'CDH2', 'PLCE1', 'MYH9', 'FYN', 'PARVA', 'PLCG1', 'PTK2']",0.9894960016567331,0,0,9
171,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.38197137150884436,1.1500045318589684,1.106775420914475,"['PPP3CA', 'MAP2K4', 'MAP2K1', 'TGFB1', 'ROCK2', 'RAC1', 'CALM1', 'PRKG1', 'FGFR2', 'IGF1R', 'MYLK', 'MAP2K6']",0.9894960016567331,0,0,12
172,PDGF Pathway WP2526,0.3841282307108746,1.2216956967213115,1.1688926013095924,"['MAP2K4', 'MAP2K1', 'JUN', 'ARFIP2', 'PLCG1', 'RAC1', 'HRAS']",0.9894960016567331,0,0,7
173,Apoptosis Modulation by HSP70 WP384,0.38461695326744894,1.4657975460122699,1.4005803530715444,"['CASP6', 'CASP2', 'CYCS']",0.9894960016567331,0,0,3
174,Globo Sphingolipid Metabolism WP1424,0.38461695326744894,1.4657975460122699,1.4005803530715444,"['GALNT2', 'ST6GALNAC3', 'ST6GALNAC5']",0.9894960016567331,0,0,3
175,Nicotine Activity on Dopaminergic Neurons WP1602,0.38461695326744894,1.4657975460122699,1.4005803530715444,"['CHRNB2', 'ADCY2', 'PPP1CA']",0.9894960016567331,0,0,3
176,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.38461695326744894,1.4657975460122699,1.4005803530715444,"['GSK3A', 'BCL2L14', 'BCL2L2']",0.9894960016567331,0,0,3
177,Lipid Metabolism Pathway WP3965,0.3875506053476934,1.2858912891235252,1.2189077257296677,"['ACLY', 'PDHA1', 'PRKAR1A', 'PRKAR2A', 'ACACA']",0.9894960016567331,0,0,5
178,Signal transduction through IL1R WP4496,0.3875506053476934,1.2858912891235252,1.2189077257296677,"['JUN', 'TGFB1', 'TOLLIP', 'IL1RAP', 'MAP2K6']",0.9894960016567331,0,0,5
179,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.39564207025362186,1.1846605470388145,1.0984709710768001,"['EIF4A2', 'RPTOR', 'MAP2K4', 'MAP2K1', 'RPS6KB1', 'RPS6KA2', 'RPS6', 'MAP2K6']",0.9894960016567331,0,0,8
180,Copper homeostasis WP3286,0.4025649806907013,1.2215821812596006,1.1115161027361433,"['PRNP', 'JUN', 'APC', 'COX17', 'ADAM10', 'SOD1']",0.9894960016567331,0,0,6
181,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.4025649806907013,1.2215821812596006,1.1115161027361433,"['MAP2K4', 'MAP2K1', 'JUN', 'RPS6KA2', 'MAP3K9', 'MAP2K6']",0.9894960016567331,0,0,6
182,Estrogen Receptor Pathway WP2881,0.40563196376313965,1.628513030148186,1.4694220022963,"['JUN', 'PPARA']",0.9894960016567331,0,0,2
183,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.40563196376313965,1.628513030148186,1.4694220022963,"['ELOB', 'ELOC']",0.9894960016567331,0,0,2
184,ID signaling pathway WP53,0.40563196376313965,1.628513030148186,1.4694220022963,"['RB1', 'ID2']",0.9894960016567331,0,0,2
185,Leptin and adiponectin WP3934,0.40563196376313965,1.628513030148186,1.4694220022963,"['LEPR', 'ACACA']",0.9894960016567331,0,0,2
186,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.40563196376313965,1.628513030148186,1.4694220022963,"['ZEB2', 'TGFB1']",0.9894960016567331,0,0,2
187,DNA Mismatch Repair WP531,0.4083804976761938,1.3029156010230178,1.1668338147116943,"['POLE4', 'RPA3', 'POLE2', 'POLD2']",0.9894960016567331,0,0,4
188,Fatty Acid Biosynthesis WP357,0.4083804976761938,1.3029156010230178,1.1668338147116943,"['ACLY', 'ACSL3', 'ACACB', 'ACACA']",0.9894960016567331,0,0,4
189,Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex WP3657,0.4083804976761938,1.3029156010230178,1.1668338147116943,"['CREBBP', 'EP300', 'ZFX', 'ETV6']",0.9894960016567331,0,0,4
190,Ectoderm Differentiation WP2858,0.421528011101275,1.0797111004555262,0.9327290004569379,"['TSC22D1', 'CTNND2', 'NR2F2', 'LDB2', 'JAKMIP1', 'HDAC6', 'TRPM2', 'AHI1', 'PTPRB', 'MAFB', 'NARS2', 'ST8SIA4', 'FYN', 'PDE7A', 'FGFR2', 'ANKS1B', 'CDON', 'LY6E', 'ASTN1']",0.9894960016567331,0,0,19
191,Energy Metabolism WP1541,0.42348739314527534,1.14969698796997,0.9878559061316278,"['ESRRA', 'MEF2A', 'PPP3CA', 'PRMT1', 'EP300', 'PPARG', 'PPARA', 'PPARGC1A']",0.9894960016567331,0,0,8
192,Bladder cancer WP2828,0.4239047315318877,1.2214687819856704,1.0483213543670171,"['RB1', 'MAP2K1', 'DAPK1', 'HRAS', 'VEGFA']",0.9894960016567331,0,0,5
193,miR-517 relationship with ARCN1 and USP1 WP3596,0.4281676829547719,2.442543411644535,2.071863945608451,['ID2'],0.9894960016567331,0,0,1
194,Platelet-mediated interactions with vascular and circulating cells WP4462,0.4281676829547719,2.442543411644535,2.071863945608451,['TGFB1'],0.9894960016567331,0,0,1
195,SARS-CoV-2 altering angiogenesis via NRP1 WP5065,0.4281676829547719,2.442543411644535,2.071863945608451,['VEGFA'],0.9894960016567331,0,0,1
196,Sulindac Metabolic Pathway WP2542,0.4281676829547719,2.442543411644535,2.071863945608451,['MSRB2'],0.9894960016567331,0,0,1
197,Tgif disruption of Shh signaling WP3674,0.4281676829547719,2.442543411644535,2.071863945608451,['SMAD2'],0.9894960016567331,0,0,1
198,Pathways Regulating Hippo Signaling WP4540,0.4321259284030509,1.0952351419357125,0.9189441574241588,"['SMAD2', 'PRKCE', 'IGF1R', 'LATS1', 'GNAL', 'PLCB4', 'CDH2', 'PRKAR1A', 'PRKAR2A', 'GNAQ', 'CDH13', 'RAC1', 'FGFR2']",0.9894960016567331,0,0,13
199,Peptide GPCRs WP24,0.4339908514811257,1.332403792526492,1.1121998488935414,"['OPRD1', 'ATP8A1', 'TACR1']",0.9894960016567331,0,0,3
200,Signaling of Hepatocyte Growth Factor Receptor WP313,0.43522181487112077,1.1725960061443932,0.9754819826846185,"['MAP2K1', 'JUN', 'RAP1A', 'PTK2B', 'HRAS', 'PTK2']",0.9894960016567331,0,0,6
201,Target Of Rapamycin (TOR) Signaling WP1471,0.43522181487112077,1.1725960061443932,0.9754819826846185,"['RPTOR', 'IDI1', 'RRAGA', 'RPS6KB1', 'RICTOR', 'RAC1']",0.9894960016567331,0,0,6
202,Selenium Micronutrient Network WP15,0.4440399862073372,1.1400102459016392,0.9255066722401367,"['GPX4', 'FLAD1', 'SELENOP', 'SELENOW', 'PLAT', 'TXN', 'SOD1']",0.9894960016567331,0,0,7
203,Cardiac Progenitor Differentiation WP2406,0.4494654518628416,1.2213554987212276,0.9767134575093036,"['MESP1', 'TGFB1', 'NOG', 'THY1']",0.9894960016567331,0,0,4
204,Cell migration and invasion through p75NTR WP4561,0.4494654518628416,1.2213554987212276,0.9767134575093036,"['JUN', 'TRIO', 'RAC1', 'EFNA5']",0.9894960016567331,0,0,4
205,Folate Metabolism WP176,0.4494654518628416,1.2213554987212276,0.9767134575093036,"['GPX4', 'FLAD1', 'PLAT', 'SOD1']",0.9894960016567331,0,0,4
206,PDGFR-beta pathway WP3972,0.4598304729648212,1.1631817517180874,0.9036728721914041,"['MAP2K4', 'MAP2K1', 'JUN', 'PLCG1', 'HRAS']",0.9894960016567331,0,0,5
207,Apoptosis Modulation and Signaling WP1772,0.46247902117788126,1.0856849666495638,0.8372303945294095,"['JUN', 'ENDOG', 'CRADD', 'CASP6', 'TOLLIP', 'CASP2', 'HTRA2', 'CYCS', 'BIRC6', 'BCL2L2']",0.9894960016567331,0,0,10
208,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.46705237804308636,1.0748151950718685,0.8182717146760804,"['RPTOR', 'CREB3', 'MAP2K1', 'THRA', 'RPS6KB1', 'RPS6', 'ZNF516', 'PPARG', 'ADCY8', 'HRAS', 'PPARGC1A']",0.9894960016567331,0,0,11
209,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.46754341546058,1.1273779983457404,0.857103854994975,"['GABRA2', 'GABRB2', 'GABRB1', 'PLCG1', 'GABRD', 'GABRG3']",0.9894960016567331,0,0,6
210,Genes targeted by miRNAs in adipocytes WP1992,0.4683890533198204,1.3957223154974816,1.0585939895053502,"['TMSB4X', 'PTBP2']",0.9894960016567331,0,0,2
211,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.4683890533198204,1.3957223154974816,1.0585939895053502,"['GRM5', 'GPRC5B']",0.9894960016567331,0,0,2
212,GPR40 Pathway WP3958,0.4683890533198204,1.3957223154974816,1.0585939895053502,"['PLCE1', 'PLCG1']",0.9894960016567331,0,0,2
213,RAS and bradykinin pathways in COVID-19 WP4969,0.4683890533198204,1.3957223154974816,1.0585939895053502,"['KLKB1', 'PRKG1']",0.9894960016567331,0,0,2
214,TCA cycle in senescence WP5050,0.4683890533198204,1.3957223154974816,1.0585939895053502,"['PDHA1', 'GOT1']",0.9894960016567331,0,0,2
215,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.4736616933081737,1.1031200423056584,0.8243196221045263,"['VAV3', 'RPS6KB1', 'ABL1', 'PTK2B', 'RNF7', 'APOE', 'PTK2']",0.9894960016567331,0,0,7
216,RANKL/RANK signaling pathway WP2018,0.4736616933081737,1.1031200423056584,0.8243196221045263,"['MAP2K1', 'JUN', 'RAC1', 'PLCG1', 'PAPSS2', 'PTK2', 'MAP2K6']",0.9894960016567331,0,0,7
217,Gastric Cancer Network 1 WP2361,0.48180644549525403,1.2212423312883436,0.8917667955726947,"['APC', 'H3F3A', 'GATD3B']",0.9894960016567331,0,0,3
218,One-carbon metabolism WP241,0.48180644549525403,1.2212423312883436,0.8917667955726947,"['AHCYL2', 'ALDH1L1', 'GLRX']",0.9894960016567331,0,0,3
219,Toll-like Receptor Signaling related to MyD88 WP3858,0.48180644549525403,1.2212423312883436,0.8917667955726947,"['TICAM2', 'TOLLIP', 'TIRAP']",0.9894960016567331,0,0,3
220,Toll-like Receptor Signaling Pathway WP75,0.4830506201717347,1.0723452157598499,0.780274653372439,"['MAP2K4', 'MAP2K1', 'JUN', 'TICAM2', 'TOLLIP', 'SPP1', 'RAC1', 'TIRAP', 'MAP2K6']",0.9894960016567331,0,0,9
221,Head and Neck Squamous Cell Carcinoma WP4674,0.4868259146474123,1.061971579628349,0.7644588446727656,"['RB1', 'RPTOR', 'RPS6', 'NUMB', 'RICTOR', 'CSMD3', 'HRAS', 'FGFR2', 'IGF1R', 'VEGFA']",0.9894960016567331,0,0,10
222,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.4895879851122463,1.1493907025725891,0.8208845967488304,"['FGD4', 'HSPB8', 'RAB11A', 'DNM2']",0.9894960016567331,0,0,4
223,Lung fibrosis WP3624,0.4895879851122463,1.1493907025725891,0.8208845967488304,"['CEBPB', 'TGFB1', 'FAM13A', 'SPP1']",0.9894960016567331,0,0,4
224,Sphingolipid Metabolism (integrated pathway) WP4726,0.4895879851122463,1.1493907025725891,0.8208845967488304,"['SGPL1', 'CERS5', 'CERS6', 'SGMS1']",0.9894960016567331,0,0,4
225,BDNF-TrkB Signaling WP3676,0.49507405046409514,1.110193542383921,0.7805192726548306,"['MAP2K1', 'HOMER1', 'RPS6KB1', 'PLCG1', 'HRAS']",0.9894960016567331,0,0,5
226,G13 Signaling Pathway WP524,0.49934155913767675,1.0855094726062469,0.7538482600547234,"['RPS6KB1', 'ROCK2', 'CFL2', 'RAC1', 'PFN1', 'CALM1']",0.9894960016567331,0,0,6
227,Prader-Willi and Angelman Syndrome WP3998,0.49934155913767675,1.0855094726062469,0.7538482600547234,"['RB1', 'FEZ2', 'NDN', 'UBE3A', 'GABRG3', 'GABRD']",0.9894960016567331,0,0,6
228,Gastrin signaling pathway WP4659,0.500844060415171,1.0319944357503044,0.7135833710013711,"['MAP2K1', 'JUN', 'PRKCE', 'RPS6', 'PTK2', 'VEGFA', 'TJP1', 'KAT5', 'RPS6KB1', 'GNAQ', 'PPARG', 'FYN', 'PLCG1', 'RAC1', 'HRAS']",0.9894960016567331,0,0,15
229,Chemokine signaling pathway WP3929,0.5050950942415139,1.0251745050921157,0.7002029645274392,"['VAV3', 'MAP2K1', 'ROCK2', 'ADCY2', 'ADCY8', 'PTK2', 'CX3CL1', 'TIAM2', 'GNG10', 'ADCY9', 'RAP1A', 'PLCB4', 'GRK5', 'GNB2', 'PTK2B', 'RAC1', 'HRAS']",0.9894960016567331,0,0,17
230,Prolactin Signaling Pathway WP2037,0.5109057139884358,1.0392672729059091,0.6979409495929088,"['MAP2K1', 'JUN', 'RPS6KB1', 'RPS6KA2', 'RPS6', 'FYN', 'RAC1', 'CTSD', 'HRAS', 'PTK2']",0.9894960016567331,0,0,10
231,ACE Inhibitor Pathway WP554,0.5253834731265016,1.6281920326864148,1.047948122248171,['TGFB1'],0.9894960016567331,0,0,1
232,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.5253834731265016,1.6281920326864148,1.047948122248171,['APOE'],0.9894960016567331,0,0,1
233,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.5253834731265016,1.6281920326864148,1.047948122248171,['COX8A'],0.9894960016567331,0,0,1
234,Cytokines and Inflammatory Response WP530,0.5253834731265016,1.6281920326864148,1.047948122248171,['TGFB1'],0.9894960016567331,0,0,1
235,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.5253834731265016,1.6281920326864148,1.047948122248171,['ID2'],0.9894960016567331,0,0,1
236,Hypothetical Craniofacial Development Pathway WP3655,0.5253834731265016,1.6281920326864148,1.047948122248171,['ARHGAP29'],0.9894960016567331,0,0,1
237,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.5253834731265016,1.6281920326864148,1.047948122248171,['APOE'],0.9894960016567331,0,0,1
238,Nanoparticle triggered regulated necrosis WP2513,0.5253834731265016,1.6281920326864148,1.047948122248171,['FTL'],0.9894960016567331,0,0,1
239,"Phase I biotransformations, non P450 WP136",0.5253834731265016,1.6281920326864148,1.047948122248171,['PON2'],0.9894960016567331,0,0,1
240,PTF1A related regulatory pathway WP4147,0.5253834731265016,1.6281920326864148,1.047948122248171,['KAT2B'],0.9894960016567331,0,0,1
241,Regulation of Actin Cytoskeleton WP51,0.5260783050151315,1.0086564320932316,0.6478652798945211,"['MAP2K1', 'CHRM1', 'PPP1R12A', 'ROCK2', 'FN1', 'BRK1', 'PTK2', 'MYLK', 'FGF14', 'APC', 'CFL2', 'TMSB4X', 'RAC1', 'PFN1', 'ARHGEF7', 'FGF12', 'FGFR2', 'PAK5', 'ARHGEF6']",0.9894960016567331,0,0,19
242,Canonical and non-canonical TGF-B signaling WP3874,0.5269939379355671,1.2211292795094533,0.7822141831620187,"['SMAD2', 'TGFB1']",0.9894960016567331,0,0,2
243,Hedgehog Signaling Pathway Netpath WP47,0.5269939379355671,1.2211292795094533,0.7822141831620187,"['SUFU', 'SAP18']",0.9894960016567331,0,0,2
244,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.5269939379355671,1.2211292795094533,0.7822141831620187,"['IDI1', 'PMVK']",0.9894960016567331,0,0,2
245,NO metabolism in cystic fibrosis WP4947,0.5269939379355671,1.2211292795094533,0.7822141831620187,"['DDAH1', 'PRMT1']",0.9894960016567331,0,0,2
246,Osteopontin Signaling WP1434,0.5269939379355671,1.2211292795094533,0.7822141831620187,"['MAP2K1', 'SPP1']",0.9894960016567331,0,0,2
247,RalA downstream regulated genes WP2290,0.5269939379355671,1.2211292795094533,0.7822141831620187,"['RAC1', 'HRAS']",0.9894960016567331,0,0,2
248,Hippo-Yap signaling pathway WP4537,0.5276032396425455,1.1271826333176027,0.7207326566831909,"['LATS1', 'TNIK', 'MAP4K4']",0.9894960016567331,0,0,3
249,Methionine De Novo and Salvage Pathway WP3580,0.5276032396425455,1.1271826333176027,0.7207326566831909,"['ODC1', 'MSRB2', 'TXN']",0.9894960016567331,0,0,3
250,Nucleotide metabolism WP404,0.5276032396425455,1.1271826333176027,0.7207326566831909,"['RRM2B', 'NME2', 'OAZ1']",0.9894960016567331,0,0,3
251,Prostaglandin Synthesis and Regulation WP98,0.5276032396425455,1.1271826333176027,0.7207326566831909,"['S100A6', 'PPARG', 'PPARGC1A']",0.9894960016567331,0,0,3
252,Resistin as a regulator of inflammation WP4481,0.5284434281804731,1.0854219948849104,0.692303337547552,"['PLCB4', 'ITPR1', 'PLCE1', 'PLCG1']",0.9894960016567331,0,0,4
253,ATM Signaling Pathway WP2516,0.5294165386270655,1.0618130034266389,0.675291567780064,"['JUN', 'CRADD', 'ABL1', 'CASP2', 'TLK1']",0.9894960016567331,0,0,5
254,Genotoxicity pathway WP4286,0.5304495976731525,1.0466315558481456,0.6635961554949656,"['RPS27', 'RRM2B', 'BLOC1S2', 'ID2', 'ITPR1', 'PPM1D']",0.9894960016567331,0,0,6
255,Nucleotide Excision Repair WP4753,0.5315043011368262,1.0360469448584202,0.6548272435953103,"['POLE4', 'DDB1', 'CETN2', 'RPA3', 'POLE2', 'POLD2', 'MNAT1']",0.9894960016567331,0,0,7
256,Acute viral myocarditis WP4298,0.5325606787445752,1.028244624888721,0.6478542014129922,"['SGCD', 'ENDOG', 'TGFB1', 'CASP6', 'ABL1', 'CASP2', 'CYCS', 'FYN']",0.9894960016567331,0,0,8
257,Genes related to primary cilium development (based on CRISPR) WP4536,0.5404546557644623,1.0017815432123203,0.6164408014357206,"['BBS2', 'DYNLT1', 'IFT172', 'ARL3', 'CEP120', 'WDR19', 'SCLT1', 'TUBE1', 'RPGRIP1L', 'TMEM231', 'WDR60', 'TTC21B', 'CDK20', 'SASS6', 'IFT27', 'KIFAP3']",0.9894960016567331,0,0,16
258,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.5594759217067466,1.0054695033751206,0.5839312278034157,"['MAP2K4', 'MAP2K1', 'TOLLIP', 'MBP', 'IL1RAP', 'TANK', 'MAP2K6']",0.9894960016567331,0,0,7
259,CAMKK2  Pathway WP4874,0.5626738127644709,1.01746417604913,0.5850980572781264,"['RPTOR', 'EP300', 'RAC1', 'ARHGEF7', 'CALM1']",0.9894960016567331,0,0,5
260,Hepatitis C and Hepatocellular Carcinoma WP3646,0.5626738127644709,1.01746417604913,0.5850980572781264,"['JUN', 'TGFB1', 'COL4A2', 'RAC1', 'VEGFA']",0.9894960016567331,0,0,5
261,IL-5 signaling pathway WP127,0.5626738127644709,1.01746417604913,0.5850980572781264,"['GSK3A', 'MAP2K1', 'JUN', 'RPS6KB1', 'RPS6']",0.9894960016567331,0,0,5
262,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.5710479501034296,1.0465600350569675,0.586368851276054,"['TICAM2', 'PLAT', 'TIRAP']",0.9894960016567331,0,0,3
263,Mitochondrial Gene Expression WP391,0.5710479501034296,1.0465600350569675,0.586368851276054,"['ESRRA', 'PPP3CA', 'PPARGC1A']",0.9894960016567331,0,0,3
264,Monoamine GPCRs WP58,0.5710479501034296,1.0465600350569675,0.586368851276054,"['CHRM1', 'HRH2', 'HTR4']",0.9894960016567331,0,0,3
265,Purine metabolism and related disorders WP4224,0.5710479501034296,1.0465600350569675,0.586368851276054,"['GRM5', 'RRM2B', 'APRT']",0.9894960016567331,0,0,3
266,7q11.23 copy number variation syndrome WP4932,0.5781214908827012,0.9765673175745119,0.5351308045000803,"['RB1', 'UBE2E1', 'ATP5MC3', 'ACACB', 'ACACA', 'HDAC6', 'ATP5F1E', 'ATP5MC1', 'CLIP2', 'ATP5F1B', 'EIF4H', 'PRKG1', 'ATF4']",0.9894960016567331,0,0,13
267,ESC Pluripotency Pathways WP3931,0.5787954911020932,0.9765793528505393,0.5339995222082956,"['MAP2K1', 'JUN', 'FGF14', 'WNT5B', 'APC', 'SELENOP', 'NOG', 'LIFR', 'FGF12', 'HRAS', 'FGFR2', 'MAP2K6']",0.9894960016567331,0,0,12
268,BMP Signaling Pathway in Eyelid Development WP3927,0.581044731048496,1.085334695963209,0.5892580914954038,"['JUN', 'FGFR2']",0.9894960016567331,0,0,2
269,Cell Differentiation - Index expanded WP2023,0.581044731048496,1.085334695963209,0.5892580914954038,"['MEF2A', 'ID2']",0.9894960016567331,0,0,2
270,FOXA2 pathway WP5066,0.581044731048496,1.085334695963209,0.5892580914954038,"['ACACA', 'SLC27A5']",0.9894960016567331,0,0,2
271,NOTCH1 regulation of endothelial cell calcification WP3413,0.581044731048496,1.085334695963209,0.5892580914954038,"['PLAT', 'VEGFA']",0.9894960016567331,0,0,2
272,Overview of nanoparticle effects WP3287,0.581044731048496,1.085334695963209,0.5892580914954038,"['FN1', 'PTK2']",0.9894960016567331,0,0,2
273,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.581044731048496,1.085334695963209,0.5892580914954038,"['BCL2L2', 'VEGFA']",0.9894960016567331,0,0,2
274,Riboflavin and CoQ disorders WP5037,0.581044731048496,1.085334695963209,0.5892580914954038,"['FLAD1', 'COQ8A']",0.9894960016567331,0,0,2
275,TP53 network WP1742,0.581044731048496,1.085334695963209,0.5892580914954038,"['SUMO1', 'ABL1']",0.9894960016567331,0,0,2
276,TYROBP causal network in microglia WP3945,0.581044731048496,1.085334695963209,0.5892580914954038,"['DPYD', 'SPP1']",0.9894960016567331,0,0,2
277,MET in type 1 papillary renal cell carcinoma WP4205,0.58226489013828,0.9766153846153847,0.5281827003060856,"['MAP2K1', 'JUN', 'RAP1A', 'RPL11', 'RAC1', 'PLCG1', 'HRAS', 'PAK5', 'PTK2']",0.9894960016567331,0,0,9
278,Proteasome Degradation WP183,0.58226489013828,0.9766153846153847,0.5281827003060856,"['PSMB6', 'PSMC5', 'PSMD7', 'PSMB5', 'PSMC6', 'UBB', 'H2AFZ', 'PSMD2', 'PSMA7']",0.9894960016567331,0,0,9
279,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.5900391224562404,0.9766513056835637,0.5152484476096735,"['MAP2K1', 'JUN', 'DLG1', 'FYN', 'PLCG1', 'CALM1']",0.9894960016567331,0,0,6
280,Amyotrophic lateral sclerosis (ALS) WP2447,0.5946955583668994,0.9766632548618219,0.5075774322019649,"['GRIA1', 'PPP3CA', 'RAC1', 'MAP2K6', 'SOD1']",0.9894960016567331,0,0,5
281,Endoderm differentiation WP2853,0.5947774189052399,0.964373534625722,0.501057656892275,"['SMAD2', 'VAV3', 'TGFB1', 'NOG', 'PBX3', 'CDYL', 'EMSY', 'ACACA', 'CDC73', 'PIAS1', 'DDAH1', 'APC', 'RFX7', 'UBR5', 'TOX', 'BPTF']",0.9894960016567331,0,0,16
282,Acetylcholine Synthesis WP528,0.6060788121986052,1.2210163432073544,0.611418131879563,['PDHA1'],0.9894960016567331,0,0,1
283,Peroxiredoxin 2 induced ovarian failure WP4873,0.6060788121986052,1.2210163432073544,0.611418131879563,['PARP2'],0.9894960016567331,0,0,1
284,Somatroph axis (GH) and its relationship to dietary restriction and aging WP4186,0.6060788121986052,1.2210163432073544,0.611418131879563,['IGF1R'],0.9894960016567331,0,0,1
285,Vitamin B12 Disorders WP4271,0.6060788121986052,1.2210163432073544,0.611418131879563,['CUBN'],0.9894960016567331,0,0,1
286,Vitamin D Metabolism WP1531,0.6060788121986052,1.2210163432073544,0.611418131879563,['RXRB'],0.9894960016567331,0,0,1
287,16p11.2 distal deletion syndrome WP4950,0.6119172046830976,0.9766871165644172,0.4797079760755241,"['ATXN2L', 'CD81', 'PRMT1']",0.9894960016567331,0,0,3
288,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.6119172046830976,0.9766871165644172,0.4797079760755241,"['RPS6KB1', 'RPS6', 'SGK1']",0.9894960016567331,0,0,3
289,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.6119172046830976,0.9766871165644172,0.4797079760755241,"['SGPL1', 'GALNT1', 'ST6GALNAC3']",0.9894960016567331,0,0,3
290,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.6119172046830976,0.9766871165644172,0.4797079760755241,"['RB1', 'GOT1', 'MDH2']",0.9894960016567331,0,0,3
291,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.6119172046830976,0.9766871165644172,0.4797079760755241,"['LATS1', 'RAP1A', 'RAC1']",0.9894960016567331,0,0,3
292,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.6119172046830976,0.9766871165644172,0.4797079760755241,"['ITPR1', 'PLOD2', 'P4HB']",0.9894960016567331,0,0,3
293,Thermogenesis WP4321,0.6152354276563291,0.949228791773779,0.4610881468613814,"['RPS6', 'ADCY2', 'ACSL3', 'ADCY8', 'RPTOR', 'CREB3', 'ADCY9', 'RPS6KB1', 'RPS6KA2', 'ZNF516', 'PPARG', 'PPARGC1A', 'HRAS', 'PRKG1']",0.9894960016567331,0,0,14
294,Wnt signaling WP428,0.6217931138089128,0.9421268777693721,0.44764956607709405,"['PPP3CA', 'JUN', 'PLCB4', 'WNT5B', 'APC', 'ROCK2', 'PRICKLE2', 'ROR1', 'RAC1', 'PRICKLE1', 'CXXC4']",0.9894960016567331,0,0,11
295,Fas ligand pathway and stress induction of heat shock proteins WP314,0.6253635638443039,0.9390008660735375,0.4407877549027222,"['RB1', 'MAP2K4', 'JUN', 'CASP6', 'CYCS']",0.9894960016567331,0,0,5
296,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.6253635638443039,0.9390008660735375,0.4407877549027222,"['LATS1', 'ITGB5', 'SGMS1', 'PAK5', 'MAP4K4']",0.9894960016567331,0,0,5
297,Notch Signaling WP268,0.6253635638443039,0.9390008660735375,0.4407877549027222,"['KAT2B', 'CREBBP', 'APH1B', 'NUMB', 'MAML3']",0.9894960016567331,0,0,5
298,p38 MAPK Signaling Pathway WP400,0.6253635638443039,0.9390008660735375,0.4407877549027222,"['MAP2K4', 'MAP3K9', 'RAC1', 'HRAS', 'MAP2K6']",0.9894960016567331,0,0,5
299,GDNF/RET signaling axis WP4830,0.6303959390205808,0.9766990291262136,0.4506559470508769,"['IFT27', 'SLIT2']",0.9894960016567331,0,0,2
300,Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,0.6303959390205808,0.9766990291262136,0.4506559470508769,"['ECI1', 'ACSL3']",0.9894960016567331,0,0,2
301,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.6303959390205808,0.9766990291262136,0.4506559470508769,"['PPARG', 'PPARA']",0.9894960016567331,0,0,2
302,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.6303959390205808,0.9766990291262136,0.4506559470508769,"['LDHA', 'PDHA1']",0.9894960016567331,0,0,2
303,Urea cycle and metabolism of amino groups WP497,0.6303959390205808,0.9766990291262136,0.4506559470508769,"['ODC1', 'CKB']",0.9894960016567331,0,0,2
304,Nuclear Receptors Meta-Pathway WP2882,0.6319160724919649,0.947897582555074,0.4350837489725199,"['SRXN1', 'ABHD2', 'TXN', 'AKAP13', 'EPB41L4B', 'FGD4', 'RGS2', 'NRIP1', 'EP300', 'LRRC8A', 'SLC39A7', 'PPARGC1A', 'GSTM4', 'JUN', 'TGFB1', 'NCOA3', 'AIP', 'SLC39A13', 'KAT2B', 'PSMC5', 'NAV3', 'CDC37', 'MFGE8', 'PPARA', 'SLC27A5', 'FKBP5', 'FTL']",0.9894960016567331,0,0,27
305,Apoptosis WP254,0.63290491562723,0.9299260452515193,0.4253807952758807,"['MAP2K4', 'JUN', 'CRADD', 'CASP6', 'CASP2', 'CYCS', 'BCL2L2', 'IGF1R']",0.9894960016567331,0,0,8
306,Melatonin metabolism and effects WP3298,0.6352511057937391,0.9300694190719766,0.4220049697937488,"['PER1', 'MAP2', 'APOE', 'CALM1']",0.9894960016567331,0,0,4
307,Kit receptor signaling pathway WP304,0.6384158258291822,0.9236541869738591,0.41450408069273437,"['MAP2K1', 'RPS6KB1', 'RPS6', 'EP300', 'FYN', 'PLCG1', 'HRAS']",0.9894960016567331,0,0,7
308,Notch Signaling Pathway Netpath WP61,0.6384158258291822,0.9236541869738591,0.41450408069273437,"['TLE1', 'APH1B', 'FHL1', 'NUMB', 'EP300', 'MAML3', 'SKP1']",0.9894960016567331,0,0,7
309,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.6384158258291822,0.9236541869738591,0.41450408069273437,"['RPTOR', 'HOMER1', 'RPS6KB1', 'NF1', 'UBE3A', 'CACNA1C', 'HRAS']",0.9894960016567331,0,0,7
310,IL-7 signaling pathway WP205,0.6500803051657817,0.9155483128834356,0.3942894663279854,"['MAP2K1', 'PTK2B', 'FYN']",0.9894960016567331,0,0,3
311,Unfolded protein response WP4925,0.6500803051657817,0.9155483128834356,0.3942894663279854,"['PPP1R15A', 'CASP2', 'ATF4']",0.9894960016567331,0,0,3
312,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.6500803051657817,0.9155483128834356,0.3942894663279854,"['BCL9', 'APC', 'RUNX1T1']",0.9894960016567331,0,0,3
313,Disruption of postsynaptic signaling by CNV WP4875,0.6545894939435023,0.904128283862163,0.38312161772739606,"['TJP1', 'DLG1', 'NLGN4X', 'HOMER1', 'NRXN1']",0.9894960016567331,0,0,5
314,Nephrotic syndrome WP4758,0.6545894939435023,0.904128283862163,0.38312161772739606,"['CUBN', 'TTC21B', 'PLCE1', 'MYH9', 'GPC5']",0.9894960016567331,0,0,5
315,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.6560449974796067,0.9082044985874864,0.38283171744465916,"['CACNG7', 'SGCD', 'ITGB5', 'CDH2', 'CACNA1C', 'CACNG2', 'SLC8A1', 'CACNG4']",0.9894960016567331,0,0,8
316,Pancreatic adenocarcinoma pathway WP4263,0.6616816611781721,0.9099989559043609,0.37580291769957913,"['RB1', 'SMAD2', 'MAP2K1', 'TGFB1', 'RPS6KB1', 'PEBP1', 'RAC1', 'PLD1', 'PAK5', 'ARHGEF6', 'VEGFA']",0.9894960016567331,0,0,11
317,Regulation of toll-like receptor signaling pathway WP1449,0.6616816611781721,0.9099989559043609,0.37580291769957913,"['MAP2K4', 'MAP2K1', 'JUN', 'CUEDC2', 'TICAM2', 'TOLLIP', 'PELI3', 'SPP1', 'RAC1', 'TIRAP', 'MAP2K6']",0.9894960016567331,0,0,11
318,AGE/RAGE pathway WP2324,0.6628312249497977,0.89925312769629,0.3698042555404712,"['SMAD2', 'MAP2K1', 'JUN', 'CYCS', 'RAC1', 'TIRAP', 'SOD1']",0.9894960016567331,0,0,7
319,Small cell lung cancer WP4658,0.6663243872441771,0.9038823328202497,0.36695693745046165,"['RB1', 'RXRB', 'LAMA5', 'COL4A2', 'FN1', 'CYCS', 'FHIT', 'RXRG', 'PTK2', 'SKP1']",0.9894960016567331,0,0,10
320,Alpha 6 Beta 4 signaling pathway WP244,0.6671457388352754,0.8877005347593583,0.35929391345705036,"['LAMA5', 'RAC1', 'HRAS', 'PTK2']",0.9894960016567331,0,0,4
321,Base Excision Repair WP4752,0.6671457388352754,0.8877005347593583,0.35929391345705036,"['POLE4', 'PARP2', 'POLE2', 'POLD2']",0.9894960016567331,0,0,4
322,Development of ureteric collection system WP5053,0.6671457388352754,0.8877005347593583,0.35929391345705036,"['ANOS1', 'SLIT2', 'ETV4', 'FGFR2']",0.9894960016567331,0,0,4
323,Nanoparticle-mediated activation of receptor signaling WP2643,0.6671457388352754,0.8877005347593583,0.35929391345705036,"['MAP2K1', 'FN1', 'HRAS', 'PTK2']",0.9894960016567331,0,0,4
324,G1 to S cell cycle control WP45,0.671335274179925,0.8875855327468231,0.3536909441208988,"['RB1', 'CREB3', 'ATF6B', 'RPA3', 'POLE2', 'MNAT1']",0.9894960016567331,0,0,6
325,T-cell receptor (TCR) signaling pathway WP69,0.671788294873704,0.8965149136577708,0.3566444136788223,"['VAV3', 'MAP2K1', 'JUN', 'TGFB1', 'ITPR1', 'PTK2B', 'FYN', 'PLCG1', 'HRAS']",0.9894960016567331,0,0,9
326,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.6730599235505315,0.9767109295199183,0.38670028378297827,['VEGFA'],0.9894960016567331,0,0,1
327,ATR Signaling WP3875,0.6730599235505315,0.9767109295199183,0.38670028378297827,['TOPBP1'],0.9894960016567331,0,0,1
328,Biomarkers for urea cycle disorders WP4583,0.6730599235505315,0.9767109295199183,0.38670028378297827,['GOT1'],0.9894960016567331,0,0,1
329,Caloric restriction and aging WP4191,0.6730599235505315,0.9767109295199183,0.38670028378297827,['PPARGC1A'],0.9894960016567331,0,0,1
330,Disorders of Folate Metabolism and Transport WP4259,0.6730599235505315,0.9767109295199183,0.38670028378297827,['ALDH1L1'],0.9894960016567331,0,0,1
331,Eicosanoid Synthesis WP167,0.6730599235505315,0.9767109295199183,0.38670028378297827,['PTGES2'],0.9894960016567331,0,0,1
332,exRNA mechanism of action and biogenesis WP2805,0.6730599235505315,0.9767109295199183,0.38670028378297827,['DICER1'],0.9894960016567331,0,0,1
333,IL1 and megakaryocytes in obesity WP2865,0.6730599235505315,0.9767109295199183,0.38670028378297827,['TIMP2'],0.9894960016567331,0,0,1
334,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.6730599235505315,0.9767109295199183,0.38670028378297827,['ADK'],0.9894960016567331,0,0,1
335,Pilocytic astrocytoma WP2253,0.6730599235505315,0.9767109295199183,0.38670028378297827,['NF1'],0.9894960016567331,0,0,1
336,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.6730599235505315,0.9767109295199183,0.38670028378297827,['JUN'],0.9894960016567331,0,0,1
337,Sulfation Biotransformation Reaction WP692,0.6730599235505315,0.9767109295199183,0.38670028378297827,['PAPSS2'],0.9894960016567331,0,0,1
338,Heart Development WP1591,0.6750829846378681,0.8878153017141265,0.3488400824633048,"['VEGFB', 'VEGFA']",0.9894960016567331,0,0,2
339,Kallmann's Syndrome WP5074,0.6750829846378681,0.8878153017141265,0.3488400824633048,"['ANOS1', 'ASCL1']",0.9894960016567331,0,0,2
340,MAPK pathway in congenital thyroid cancer WP4928,0.6750829846378681,0.8878153017141265,0.3488400824633048,"['MAP2K1', 'JUN']",0.9894960016567331,0,0,2
341,Endothelin Pathways WP2197,0.6854828925255435,0.8616023096355107,0.3253683763516596,"['MAP2K1', 'CALM1', 'MYLK']",0.9894960016567331,0,0,3
342,Sphingolipid Metabolism (general overview) WP4725,0.6854828925255435,0.8616023096355107,0.3253683763516596,"['SGPL1', 'CERS6', 'SGMS1']",0.9894960016567331,0,0,3
343,Ras signaling WP4223,0.6942149342089876,0.9065727828159675,0.3308751892772846,"['MAP2K1', 'PLA2G12A', 'RASAL2', 'KSR2', 'PLD1', 'IGF1R', 'GNG10', 'RAP1A', 'GNB2', 'RASA2', 'ABL1', 'NF1', 'PLCE1', 'CALM3', 'SHOC2', 'PLCG1', 'RAC1', 'CALM1', 'HRAS', 'FGFR2', 'PAK5']",0.9894960016567331,0,0,21
344,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.6970712211254255,0.8490159012565328,0.3063824079532669,"['MAP2K1', 'PLCB4', 'PRKCE', 'HRAS']",0.9894960016567331,0,0,4
345,Neural Crest Cell Migration during Development WP4564,0.6970712211254255,0.8490159012565328,0.3063824079532669,"['JUN', 'TRIO', 'RAC1', 'PAK5']",0.9894960016567331,0,0,4
346,22q11.2 copy number variation syndrome WP4657,0.6990829739864438,0.8799777830141045,0.3150195857894699,"['PRKN', 'RANBP1', 'MAG', 'AIFM3', 'SHOC2', 'ZDHHC8', 'HIST1H4C', 'TNPO1', 'RTN4', 'FGFR2', 'RAN']",0.9894960016567331,0,0,11
347,mRNA Processing WP411,0.7132164780027804,0.891142942109437,0.30117983762942024,"['SRPK2', 'SF3B5', 'SF3A1', 'RNGTT', 'CPSF1', 'PRMT1', 'DDX20', 'HNRNPR', 'DICER1', 'PRPF8', 'PTBP2', 'LSM2', 'HNRNPK', 'CD2BP2', 'SRSF3', 'SREK1', 'CLASRP', 'HNRNPA1', 'SRSF7']",0.9894960016567331,0,0,19
348,Complement and Coagulation Cascades WP558,0.7152649622635566,0.8137455288707205,0.2726879400281531,"['PLAT', 'KLKB1']",0.9894960016567331,0,0,2
349,Microglia Pathogen Phagocytosis Pathway WP3937,0.7152649622635566,0.8137455288707205,0.2726879400281531,"['VAV3', 'RAC1']",0.9894960016567331,0,0,2
350,Urea cycle and associated pathways WP4595,0.7152649622635566,0.8137455288707205,0.2726879400281531,"['GOT1', 'MDH2']",0.9894960016567331,0,0,2
351,DNA damage response WP707,0.7194173493334114,0.8366908053543998,0.27553368765265474,"['RB1', 'RRM2B', 'TLK2', 'ABL1', 'TLK1', 'CYCS']",0.9894960016567331,0,0,6
352,DNA Replication WP466,0.7250136385192743,0.8135549872122763,0.26161065696502545,"['RPA3', 'POLE2', 'POLD2', 'UBA52']",0.9894960016567331,0,0,4
353,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.7250136385192743,0.8135549872122763,0.26161065696502545,"['PPP3CA', 'CREBBP', 'SUPT4H1', 'EP300']",0.9894960016567331,0,0,4
354,Cancer immunotherapy by PD-1 blockade WP4585,0.728656558198377,0.8138406537282942,0.25762351454981847,['JUN'],0.9894960016567331,0,0,1
355,Cell Differentiation - Index WP2029,0.728656558198377,0.8138406537282942,0.25762351454981847,['MEF2A'],0.9894960016567331,0,0,1
356,"Cerebral organic acidurias, including diseases WP4519",0.728656558198377,0.8138406537282942,0.25762351454981847,['MDH2'],0.9894960016567331,0,0,1
357,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.728656558198377,0.8138406537282942,0.25762351454981847,['TGFB1'],0.9894960016567331,0,0,1
358,Mevalonate pathway WP3963,0.728656558198377,0.8138406537282942,0.25762351454981847,['PMVK'],0.9894960016567331,0,0,1
359,Neuroinflammation WP4919,0.728656558198377,0.8138406537282942,0.25762351454981847,['JUN'],0.9894960016567331,0,0,1
360,Osteoclast Signaling WP12,0.728656558198377,0.8138406537282942,0.25762351454981847,['SPP1'],0.9894960016567331,0,0,1
361,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.728656558198377,0.8138406537282942,0.25762351454981847,['ANAPC11'],0.9894960016567331,0,0,1
362,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.728656558198377,0.8138406537282942,0.25762351454981847,['MEF2A'],0.9894960016567331,0,0,1
363,Thiamine metabolic pathways WP4297,0.728656558198377,0.8138406537282942,0.25762351454981847,['PDHA1'],0.9894960016567331,0,0,1
364,IL-1 signaling pathway WP195,0.7297627490629237,0.8331917233106757,0.2624852202298141,"['MAP2K4', 'MAP2K1', 'JUN', 'TOLLIP', 'IL1RAP', 'PLCG1', 'MAP2K6']",0.9894960016567331,0,0,7
365,Rett syndrome causing genes WP4312,0.7297627490629237,0.8331917233106757,0.2624852202298141,"['KCNJ10', 'TRRAP', 'TBL1XR1', 'SATB2', 'HIVEP2', 'SCN2A', 'GABRD']",0.9894960016567331,0,0,7
366,Glioblastoma signaling pathways WP2261,0.7407903048416798,0.8411917694308311,0.25238922958701826,"['RB1', 'MAP2K4', 'MAP2K1', 'NF1', 'EP300', 'PLCG1', 'HRAS', 'FGFR2', 'IGF1R', 'MAP2K6']",0.9894960016567331,0,0,10
367,Phosphodiesterases in neuronal function WP4222,0.7415412822078213,0.8133640552995391,0.24321573525068757,"['GRIA1', 'ADCY9', 'PDE5A', 'ADCY2', 'ADCY8', 'PDE7A']",0.9894960016567331,0,0,6
368,Ethanol effects on histone modifications WP3996,0.7480828006661785,0.7707458831126897,0.22370252682959132,"['KAT2B', 'HAT1', 'HDAC6']",0.9894960016567331,0,0,3
369,MTHFR deficiency WP4288,0.7480828006661785,0.7707458831126897,0.22370252682959132,"['SGMS1', 'EHMT1', 'CYCS']",0.9894960016567331,0,0,3
370,Oxysterols derived from cholesterol WP4545,0.7480828006661785,0.7707458831126897,0.22370252682959132,"['EBP', 'NR1H2', 'SLC27A5']",0.9894960016567331,0,0,3
371,Amino Acid metabolism WP3925,0.7487813311998462,0.8285050798258345,0.23969338438263615,"['ACLY', 'LDHA', 'PKM', 'PDHA1', 'AUH', 'GOT1', 'MDH2', 'ODC1', 'GLUL']",0.9894960016567331,0,0,9
372,Hedgehog Signaling Pathway WP4249,0.7509879799789395,0.7809309462915601,0.22363178453007682,"['SMURF2', 'HHIP', 'SUFU', 'CDON']",0.9894960016567331,0,0,4
373,Phosphoinositides metabolism WP4971,0.7509879799789395,0.7809309462915601,0.22363178453007682,"['PIP4P1', 'PLCB4', 'PLCE1', 'PLCG1']",0.9894960016567331,0,0,4
374,"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",0.7511816111239442,0.7510711056955308,0.21488732476865768,"['MAP2K1', 'MAP2K6']",0.9894960016567331,0,0,2
375,Canonical and non-canonical Notch signaling WP3845,0.7511816111239442,0.7510711056955308,0.21488732476865768,"['ADAM10', 'MAML3']",0.9894960016567331,0,0,2
376,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.7511816111239442,0.7510711056955308,0.21488732476865768,"['JUN', 'SRXN1']",0.9894960016567331,0,0,2
377,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.7511816111239442,0.7510711056955308,0.21488732476865768,"['PPARA', 'PPARGC1A']",0.9894960016567331,0,0,2
378,Striated Muscle Contraction Pathway WP383,0.7511816111239442,0.7510711056955308,0.21488732476865768,"['TMOD1', 'MYOM1']",0.9894960016567331,0,0,2
379,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.7511816111239442,0.7510711056955308,0.21488732476865768,"['ACLY', 'PDHA1']",0.9894960016567331,0,0,2
380,Vitamin A and carotenoid metabolism WP716,0.7511816111239442,0.7510711056955308,0.21488732476865768,"['RXRB', 'RXRG']",0.9894960016567331,0,0,2
381,IL-6 signaling pathway WP364,0.7562024686009343,0.7871363951530359,0.21996221393636123,"['MAP2K4', 'CREBBP', 'MAP2K1', 'RPS6KB1', 'RAC1']",0.9894960016567331,0,0,5
382,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.7575285654210812,0.8268473184857945,0.22961056586984122,"['MAP2K1', 'RPS6KB1', 'RPS6', 'PDGFC', 'NF1', 'PLCG1', 'HRAS', 'FGFR2', 'IGF1R', 'VEGFA']",0.9894960016567331,0,0,10
383,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.7580519720374284,0.8131727319323424,0.22525155542122133,"['SMAD2', 'MAP2K1', 'JUN', 'TGFB1', 'APC', 'DCC', 'CYCS', 'RAC1']",0.9894960016567331,0,0,8
384,miRNA regulation of DNA damage response WP1530,0.7623840370371185,0.7912982106530494,0.2146830539315496,"['RB1', 'RRM2B', 'TLK2', 'ABL1', 'TLK1', 'CYCS']",0.9894960016567331,0,0,6
385,Wnt Signaling Pathway WP363,0.7623840370371185,0.7912982106530494,0.2146830539315496,"['BCL9', 'GSK3A', 'APC', 'PPARG', 'ROR1', 'RAC1']",0.9894960016567331,0,0,6
386,Cell cycle WP179,0.7658211579072245,0.8254778076133312,0.22024293698033795,"['RB1', 'SMAD2', 'TGFB1', 'STAG2', 'YWHAB', 'CDC27', 'ABL1', 'EP300', 'ANAPC10', 'SKP1', 'ANAPC11']",0.9894960016567331,0,0,11
387,"GPCRs, Class A Rhodopsin-like WP455",0.7689477966690833,0.7942718261532596,0.2086807814845384,"['OPRD1', 'CHRM1', 'GPR12', 'HRH2', 'P2RY14', 'RRH', 'HTR4']",0.9894960016567331,0,0,7
388,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.7689477966690833,0.7942718261532596,0.2086807814845384,"['ANGPT1', 'STMN1', 'FN1', 'RAC1', 'HRAS', 'ANGPTL1', 'PTK2']",0.9894960016567331,0,0,7
389,Regulatory circuits of the STAT3 signaling pathway WP4538,0.7689477966690833,0.7942718261532596,0.2086807814845384,"['RPTOR', 'CREBBP', 'IFNGR2', 'STMN1', 'IL3RA', 'LIFR', 'RICTOR']",0.9894960016567331,0,0,7
390,Autosomal recessive Osteopetrosis pathways WP4788,0.7748028612036029,0.6975047424485626,0.17796600162257378,['OSTM1'],0.9894960016567331,0,0,1
391,Dopamine metabolism WP2436,0.7748028612036029,0.6975047424485626,0.17796600162257378,['SOD1'],0.9894960016567331,0,0,1
392,Glutathione metabolism WP100,0.7748028612036029,0.6975047424485626,0.17796600162257378,['GPX4'],0.9894960016567331,0,0,1
393,Homologous recombination WP186,0.7748028612036029,0.6975047424485626,0.17796600162257378,['POLD2'],0.9894960016567331,0,0,1
394,Serotonin and anxiety-related events WP3944,0.7748028612036029,0.6975047424485626,0.17796600162257378,['PPP3CA'],0.9894960016567331,0,0,1
395,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.7748028612036029,0.6975047424485626,0.17796600162257378,['TGFB1'],0.9894960016567331,0,0,1
396,Trans-sulfuration pathway WP2333,0.7748028612036029,0.6975047424485626,0.17796600162257378,['GOT1'],0.9894960016567331,0,0,1
397,Neural Crest Cell Migration in Cancer WP4565,0.7750329364939339,0.7508164469801298,0.1913453851827565,"['JUN', 'TRIO', 'RAC1', 'PAK5']",0.9894960016567331,0,0,4
398,Neovascularisation processes WP4331,0.7754269518232741,0.7321319018404908,0.18621152299538038,"['SMAD2', 'TGFB1', 'ANGPT1']",0.9894960016567331,0,0,3
399,Non-small cell lung cancer WP4255,0.77561033741254,0.7964936871724599,0.20239305022224147,"['RB1', 'RXRB', 'MAP2K1', 'CYCS', 'PLCG1', 'HRAS', 'FHIT', 'RXRG']",0.9894960016567331,0,0,8
400,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.7831213312881894,0.6973501715453683,0.1704795493318744,"['H2AFZ', 'H3F3A']",0.9894960016567331,0,0,2
401,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.7831213312881894,0.6973501715453683,0.1704795493318744,"['LAMA5', 'FGFR2']",0.9894960016567331,0,0,2
402,Immune response to tuberculosis WP4197,0.7831213312881894,0.6973501715453683,0.1704795493318744,"['IFNGR2', 'PIAS1']",0.9894960016567331,0,0,2
403,Ovarian infertility WP34,0.7831213312881894,0.6973501715453683,0.1704795493318744,"['CEBPB', 'NRIP1']",0.9894960016567331,0,0,2
404,Pre-implantation embryo WP3527,0.7831213312881894,0.6973501715453683,0.1704795493318744,"['ESRRA', 'DLX2']",0.9894960016567331,0,0,2
405,Proteoglycan biosynthesis WP4784,0.7831213312881894,0.6973501715453683,0.1704795493318744,"['CHSY1', 'PAPSS2']",0.9894960016567331,0,0,2
406,"Relationship between inflammation, COX-2 and EGFR WP4483",0.7831213312881894,0.6973501715453683,0.1704795493318744,"['PTGES2', 'HRAS']",0.9894960016567331,0,0,2
407,SARS-CoV-2 mitochondrial interactions WP5038,0.7831213312881894,0.6973501715453683,0.1704795493318744,"['NDUFB9', 'PHB']",0.9894960016567331,0,0,2
408,Zinc homeostasis WP3529,0.7831213312881894,0.6973501715453683,0.1704795493318744,"['SLC39A13', 'SLC39A7']",0.9894960016567331,0,0,2
409,Integrated Cancer Pathway WP1971,0.7972061448525111,0.7229326513213982,0.16384688940301917,"['ATF1', 'RB1', 'SMAD2', 'POU2F1']",0.9894960016567331,0,0,4
410,Wnt signaling pathway and pluripotency WP399,0.797683505887643,0.7838736263736263,0.1771894356625601,"['MAP2K4', 'CREBBP', 'JUN', 'WNT5B', 'APC', 'PPP2R5E', 'PPP2R2B', 'PRKCE', 'EP300']",0.9894960016567331,0,0,9
411,7-oxo-C and 7beta-HC pathways WP5064,0.8113977341858136,0.6507920286152273,0.13601352998930483,"['EBP', 'SLC27A5']",0.9894960016567331,0,0,2
412,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.8113977341858136,0.6507920286152273,0.13601352998930483,"['RB1', 'H3F3A']",0.9894960016567331,0,0,2
413,Sleep regulation WP3591,0.8113977341858136,0.6507920286152273,0.13601352998930483,"['CHRNB2', 'BTBD9']",0.9894960016567331,0,0,2
414,B Cell Receptor Signaling Pathway WP23,0.8123118504142522,0.7700404858299595,0.1600690552711654,"['MAP2K1', 'JUN', 'GSK3A', 'CD81', 'FYN', 'PLCG1', 'RAC1', 'HRAS', 'MAP2K6']",0.9894960016567331,0,0,9
415,Alanine and aspartate metabolism WP106,0.8131045190582006,0.610252808988764,0.12625863203380272,['GOT1'],0.9894960016567331,0,0,1
416,Cytosine methylation WP3585,0.8131045190582006,0.610252808988764,0.12625863203380272,['TET2'],0.9894960016567331,0,0,1
417,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.8131045190582006,0.610252808988764,0.12625863203380272,['PPARA'],0.9894960016567331,0,0,1
418,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.8131045190582006,0.610252808988764,0.12625863203380272,['MAP2K1'],0.9894960016567331,0,0,1
419,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.8131045190582006,0.610252808988764,0.12625863203380272,['RB1'],0.9894960016567331,0,0,1
420,Iron metabolism in placenta WP2007,0.8131045190582006,0.610252808988764,0.12625863203380272,['TF'],0.9894960016567331,0,0,1
421,miRNAs involved in DNA damage response WP1545,0.8131045190582006,0.610252808988764,0.12625863203380272,['ABL1'],0.9894960016567331,0,0,1
422,Non-homologous end joining WP438,0.8131045190582006,0.610252808988764,0.12625863203380272,['DCLRE1C'],0.9894960016567331,0,0,1
423,Purine metabolism WP4792,0.8131045190582006,0.610252808988764,0.12625863203380272,['APRT'],0.9894960016567331,0,0,1
424,Eukaryotic Transcription Initiation WP405,0.8163985963862865,0.7174574026130411,0.14553807606278696,"['TAF7', 'POLR3H', 'MNAT1', 'POLR2J', 'POLR2K']",0.9894960016567331,0,0,5
425,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.8175799195724364,0.6970405553525758,0.140388582287254,"['RB1', 'MAP2K4', 'JUN', 'MAP2K6']",0.9894960016567331,0,0,4
426,16p11.2 proximal deletion syndrome WP4949,0.8226609913095361,0.7503055632220164,0.14646796036282153,"['TCP1', 'KCTD13', 'TMEM219', 'PPARG', 'PPP4R3B', 'CCT7', 'BPTF', 'MAP2K6']",0.9894960016567331,0,0,8
427,Oxidative Damage WP3941,0.8227870899545241,0.6654350250976018,0.1297982998290083,"['MAP2K4', 'CYCS', 'MAP3K9']",0.9894960016567331,0,0,3
428,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.8227870899545241,0.6654350250976018,0.1297982998290083,"['RPTOR', 'RICTOR', 'HRAS']",0.9894960016567331,0,0,3
429,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.8227870899545241,0.6654350250976018,0.1297982998290083,"['MAP2K1', 'RPS6', 'FYN']",0.9894960016567331,0,0,3
430,Melanoma WP4685,0.8344828746048658,0.7263690268573422,0.1314314328358673,"['RB1', 'MAP2K1', 'NF1', 'CALM3', 'RAC1', 'CALM1', 'HRAS']",0.9894960016567331,0,0,7
431,1q21.1 copy number variation syndrome WP4905,0.8363327519068396,0.6100536535513541,0.10903410649116348,"['TJP1', 'BCL9']",0.9894960016567331,0,0,2
432,Oxidation by Cytochrome P450 WP43,0.8363327519068396,0.6100536535513541,0.10903410649116348,"['CYB5B', 'CYP51A1']",0.9894960016567331,0,0,2
433,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.8363327519068396,0.6100536535513541,0.10903410649116348,"['MDH2', 'IDH3G']",0.9894960016567331,0,0,2
434,Tryptophan metabolism WP465,0.8363327519068396,0.6100536535513541,0.10903410649116348,"['PRMT1', 'DHCR24']",0.9894960016567331,0,0,2
435,Vitamin D in inflammatory diseases WP4482,0.8363327519068396,0.6100536535513541,0.10903410649116348,"['PPP3CA', 'MAP2K6']",0.9894960016567331,0,0,2
436,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.8448945154088489,0.5423901940755873,0.09141633801569207,['NOG'],0.9894960016567331,0,0,1
437,Cysteine and methionine catabolism WP4504,0.8448945154088489,0.5423901940755873,0.09141633801569207,['GOT1'],0.9894960016567331,0,0,1
438,Ganglio Sphingolipid Metabolism WP1423,0.8448945154088489,0.5423901940755873,0.09141633801569207,['ST8SIA5'],0.9894960016567331,0,0,1
439,Glycosaminoglycan degradation WP4815,0.8448945154088489,0.5423901940755873,0.09141633801569207,['ARSB'],0.9894960016567331,0,0,1
440,"GPCRs, Class B Secretin-like WP334",0.8448945154088489,0.5423901940755873,0.09141633801569207,['VIPR2'],0.9894960016567331,0,0,1
441,Mammalian disorder of sexual development WP4842,0.8448945154088489,0.5423901940755873,0.09141633801569207,['FGFR2'],0.9894960016567331,0,0,1
442,"NAD metabolism, sirtuins and aging WP3630",0.8448945154088489,0.5423901940755873,0.09141633801569207,['PPARG'],0.9894960016567331,0,0,1
443,PPAR-alpha pathway WP2878,0.8448945154088489,0.5423901940755873,0.09141633801569207,['PPARA'],0.9894960016567331,0,0,1
444,Neural Crest Differentiation WP2064,0.8481223486371525,0.6967303050252359,0.11477264410310856,"['CDH2', 'MBP', 'ASCL1', 'FGFR2', 'HDAC6', 'SOX5']",0.9894960016567331,0,0,6
445,Modulators of TCR signaling and T cell activation WP5072,0.8494549734664487,0.6774564994882293,0.11053403471966494,"['NDUFB10', 'RASA2', 'ELOB', 'RNF7', 'PLCG1']",0.9894960016567331,0,0,5
446,ErbB signaling pathway WP673,0.8536812872124582,0.7386072111572368,0.1168457070674449,"['MAP2K4', 'MAP2K1', 'JUN', 'RPS6KB1', 'NCK2', 'ABL1', 'PLCG1', 'HRAS', 'PAK5', 'PTK2']",0.9894960016567331,0,0,10
447,Gastric Cancer Network 2 WP2363,0.8582447558393633,0.5741080284949953,0.08776157317312873,"['AHCTF1', 'S100A6']",0.9894960016567331,0,0,2
448,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.8582447558393633,0.5741080284949953,0.08776157317312873,"['NDUFA13', 'RAC1']",0.9894960016567331,0,0,2
449,Leptin Insulin Overlap WP3935,0.8712794258614018,0.48810010214504596,0.06725655439846609,['LEPR'],0.9894960016567331,0,0,1
450,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.8712794258614018,0.48810010214504596,0.06725655439846609,['MAP2K6'],0.9894960016567331,0,0,1
451,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.8712794258614018,0.48810010214504596,0.06725655439846609,['ZEB1'],0.9894960016567331,0,0,1
452,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.8712794258614018,0.48810010214504596,0.06725655439846609,['APC'],0.9894960016567331,0,0,1
453,Serotonin and anxiety WP3947,0.8712794258614018,0.48810010214504596,0.06725655439846609,['PPP3CA'],0.9894960016567331,0,0,1
454,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.8712794258614018,0.48810010214504596,0.06725655439846609,['ITPR1'],0.9894960016567331,0,0,1
455,DNA IR-double strand breaks and cellular response via ATM WP3959,0.8774133514710541,0.6416662177449766,0.08391522997935617,"['LATS1', 'DCLRE1C', 'KAT5', 'ABL1', 'MCPH1']",0.9894960016567331,0,0,5
456,Estrogen signaling pathway WP712,0.8774404696929545,0.542156361778232,0.07088486608117331,"['MAP2K1', 'JUN']",0.9894960016567331,0,0,2
457,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.8774404696929545,0.542156361778232,0.07088486608117331,"['MAP2K1', 'THRA']",0.9894960016567331,0,0,2
458,Glycosylation and related congenital defects WP4521,0.8774404696929545,0.542156361778232,0.07088486608117331,"['DPM3', 'TUSC3']",0.9894960016567331,0,0,2
459,NRF2-ARE regulation WP4357,0.8774404696929545,0.542156361778232,0.07088486608117331,"['CEBPB', 'FYN']",0.9894960016567331,0,0,2
460,"GPCRs, Other WP117",0.8776993113262591,0.585398773006135,0.07636598062383577,"['ADGRV1', 'CELSR3', 'GPR135']",0.9894960016567331,0,0,3
461,MAPK Signaling Pathway WP382,0.8781674739121267,0.7953646815499726,0.10333215589824939,"['CACNA1B', 'CACNA1C', 'PPP3CA', 'CACNG7', 'RAP1A', 'STMN1', 'RAC1', 'CACNG2', 'HRAS', 'CACNG4', 'MAP4K4', 'MAP2K6', 'MAP2K4', 'HSPA8', 'JUN', 'MAP2K1', 'DUSP3', 'TGFB1', 'FGF14', 'TAOK1', 'RASA2', 'NF1', 'FGF12', 'FGFR2', 'ATF4']",0.9894960016567331,0,0,25
462,Metapathway biotransformation Phase I and II WP702,0.8837074309431493,0.6962637362637363,0.08607855070213097,"['NDST2', 'GSTM4', 'NAA30', 'GPX4', 'GSTO1', 'NAA20', 'CYP51A1', 'HS6ST1', 'NAT14']",0.9894960016567331,0,0,9
463,AMP-activated protein kinase (AMPK) signaling WP1403,0.8861706535891728,0.6500768049155146,0.07855900971886391,"['RPTOR', 'RPS6KB1', 'LEPR', 'EEF2', 'ACACB', 'ACACA']",0.9894960016567331,0,0,6
464,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.889651195485598,0.6251476261711676,0.07309589147157185,"['JUN', 'WNT5B', 'APC', 'ROR1', 'CXXC4']",0.9894960016567331,0,0,5
465,ERK Pathway in Huntington's Disease WP3853,0.8931778573343283,0.4436809360200576,0.05012243550363726,['HRAS'],0.9894960016567331,0,0,1
466,Omega-3/Omega-6 FA synthesis WP4723,0.8931778573343283,0.4436809360200576,0.05012243550363726,['ACSL3'],0.9894960016567331,0,0,1
467,Phytochemical activity on NRF2 transcriptional activation WP3,0.8931778573343283,0.4436809360200576,0.05012243550363726,['CEBPB'],0.9894960016567331,0,0,1
468,Statin inhibition of cholesterol production WP430,0.8931778573343283,0.4436809360200576,0.05012243550363726,['APOE'],0.9894960016567331,0,0,1
469,Type II diabetes mellitus WP1584,0.8931778573343283,0.4436809360200576,0.05012243550363726,['PHKA2'],0.9894960016567331,0,0,1
470,DNA Repair Pathways Full Network WP4946,0.8963615280690905,0.7195821265065869,0.07873052834488042,"['DCLRE1C', 'PARP2', 'CETN2', 'REV1', 'DDB1', 'POLE4', 'BRIP1', 'RAP1A', 'RPA3', 'POLE2', 'POLD2', 'REV3L', 'MNAT1']",0.9894960016567331,0,0,13
471,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.9067774271938679,0.6222832303820636,0.06089555009211771,"['JUN', 'HNRNPK', 'WNT5B', 'APC', 'ROR1', 'CXXC4']",0.9894960016567331,0,0,6
472,IL-9 signaling pathway WP22,0.9113523635578309,0.40666496424923393,0.0377489473025534,['MAP2K1'],0.9894960016567331,0,0,1
473,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.9113523635578309,0.40666496424923393,0.0377489473025534,['FGFR2'],0.9894960016567331,0,0,1
474,Omega-9 FA synthesis WP4724,0.9113523635578309,0.40666496424923393,0.0377489473025534,['ACSL3'],0.9894960016567331,0,0,1
475,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.9169386255565432,0.5225131463628396,0.04530959088406706,"['TGFB1', 'EP300', 'TANK']",0.9894960016567331,0,0,3
476,ATM Signaling Network in Development and Disease  WP3878,0.9174499404707134,0.5572232371209354,0.04800882806354874,"['DCLRE1C', 'KAT5', 'PPM1D', 'CDK5R1']",0.9894960016567331,0,0,4
477,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.9209444480774746,0.620193740685544,0.05107640375823964,"['ACLY', 'IDI1', 'GSK3A', 'NR1H2', 'CYP51A1', 'PPARG', 'ACACA']",0.9894960016567331,0,0,7
478,IL17 signaling pathway WP2112,0.9215266566153859,0.4645594568946638,0.037965459558479894,"['CEBPB', 'TRAF3IP2']",0.9894960016567331,0,0,2
479,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.9215266566153859,0.4645594568946638,0.037965459558479894,"['SMAD2', 'TGFB1']",0.9894960016567331,0,0,2
480,Imatinib and Chronic Myeloid Leukemia WP3640,0.9264359445368991,0.37534375736622927,0.028680156384210006,['ABL1'],0.9894960016567331,0,0,1
481,Kennedy pathway from sphingolipids WP3933,0.9264359445368991,0.37534375736622927,0.028680156384210006,['SGPL1'],0.9894960016567331,0,0,1
482,Overview of interferons-mediated signaling pathway WP4558,0.9264359445368991,0.37534375736622927,0.028680156384210006,['IFNGR2'],0.9894960016567331,0,0,1
483,Purinergic signaling WP4900,0.9264359445368991,0.37534375736622927,0.028680156384210006,['P2RY14'],0.9894960016567331,0,0,1
484,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.9267669287580462,0.541687979539642,0.04119708816654288,"['RPTOR', 'WIPI1', 'ACACA', 'FTL']",0.9894960016567331,0,0,4
485,NO/cGMP/PKG mediated Neuroprotection WP4008,0.9272170740017998,0.5044425639940766,0.03811950004823011,"['AKAP9', 'CYCS', 'CALM1']",0.9894960016567331,0,0,3
486,Allograft Rejection WP2328,0.9325487779350189,0.4433966646536907,0.030964082892290058,"['TGFB1', 'VEGFA']",0.9894960016567331,0,0,2
487,One-carbon metabolism and related pathways WP3940,0.9363149948518927,0.48757668711656443,0.03208416776919131,"['GPX4', 'PLD1', 'SOD1']",0.9894960016567331,0,0,3
488,Constitutive Androstane Receptor Pathway WP2875,0.9389540473340267,0.34849700860936816,0.021951387064537448,['PPARGC1A'],0.9894960016567331,0,0,1
489,Interactome of polycomb repressive complex 2 (PRC2)  WP2916,0.9389540473340267,0.34849700860936816,0.021951387064537448,['STK38'],0.9894960016567331,0,0,1
490,Type II interferon signaling (IFNG) WP619,0.9389540473340267,0.34849700860936816,0.021951387064537448,['IFNGR2'],0.9894960016567331,0,0,1
491,Breast cancer pathway WP4262,0.9412939673421924,0.6323589186595857,0.038257581345470006,"['RB1', 'MAP2K1', 'JUN', 'WNT5B', 'RPS6KB1', 'APC', 'NCOA3', 'HRAS', 'IGF1R', 'SKP1']",0.9894960016567331,0,0,10
492,Cytosolic DNA-sensing pathway WP4655,0.9443515972511886,0.471798931327924,0.027013662829525904,"['POLR1C', 'POLR3H', 'POLR2K']",0.9894960016567331,0,0,3
493,Retinoblastoma gene in cancer WP2446,0.9447411753134074,0.5621529008625783,0.031955175527766846,"['RB1', 'H2AFZ', 'RPA3', 'POLE2', 'STMN1', 'ABL1']",0.9894960016567331,0,0,6
494,Corticotropin-releasing hormone signaling pathway WP2355,0.9470471264678686,0.5779035843289803,0.031441666906498154,"['MAP2K1', 'TGFB1', 'GNB2', 'GNAQ', 'PLCG1', 'ACACA', 'PTK2']",0.9894960016567331,0,0,7
495,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.9493428327260528,0.32522982635342185,0.016907166444693842,['CEBPB'],0.9894960016567331,0,0,1
496,Fatty acid beta-oxidation WP143,0.9503436085093026,0.4063617782319877,0.020696682614018292,"['ECI1', 'ACSL3']",0.9894960016567331,0,0,2
497,miRNA regulation of prostate cancer signaling pathways WP3981,0.9574638394001563,0.39006642820643844,0.016955143925590256,"['CREBBP', 'MAP2K1']",0.9894960016567331,0,0,2
498,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.9579643408040079,0.30487104187946884,0.013092602824361133,['SMAD2'],0.9894960016567331,0,0,1
499,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.9579643408040079,0.30487104187946884,0.013092602824361133,['HRAS'],0.9894960016567331,0,0,1
500,NAD+ biosynthetic pathways WP3645,0.9579643408040079,0.30487104187946884,0.013092602824361133,['PARP2'],0.9894960016567331,0,0,1
501,Oxidative Stress WP408,0.9579643408040079,0.30487104187946884,0.013092602824361133,['SOD1'],0.9894960016567331,0,0,1
502,TLR4 Signaling and Tolerance WP3851,0.9579643408040079,0.30487104187946884,0.013092602824361133,['TIRAP'],0.9894960016567331,0,0,1
503,DNA damage response (only ATM dependent) WP710,0.9627112490901671,0.5644374122523567,0.02144961356732397,"['JUN', 'TGFB1', 'WNT5B', 'APC', 'PPP2R5E', 'ABL1', 'RAC1', 'HRAS']",0.9894960016567331,0,0,8
504,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.9635995289753371,0.37502456664439293,0.013905722316005278,"['JUN', 'RAC1']",0.9894960016567331,0,0,2
505,Tumor suppressor activity of SMARCB1 WP4204,0.9635995289753371,0.37502456664439293,0.013905722316005278,"['RB1', 'H3F3A']",0.9894960016567331,0,0,2
506,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9639688906110893,0.6145162598329413,0.02255044601319422,"['RPTOR', 'MAP2K4', 'MAP2K1', 'GSK3A', 'THRA', 'RPS6KB1', 'RPS6KA2', 'RICTOR', 'MAP3K9', 'HRAS', 'MAP2K6', 'MAP4K4']",0.9894960016567331,0,0,12
507,DNA IR-damage and cellular response via ATR WP4016,0.964423048373133,0.521779679613781,0.018901590873896788,"['BRIP1', 'POLN', 'UIMC1', 'TOPBP1', 'PPM1D', 'MCPH1']",0.9894960016567331,0,0,6
508,Fluoropyrimidine Activity WP1601,0.9651190812950293,0.28690740852009855,0.010186298932835158,['DPYD'],0.9894960016567331,0,0,1
509,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.9651190812950293,0.28690740852009855,0.010186298932835158,['WIPI1'],0.9894960016567331,0,0,1
510,Trans-sulfuration and one-carbon metabolism WP2525,0.9651190812950293,0.28690740852009855,0.010186298932835158,['AHCYL2'],0.9894960016567331,0,0,1
511,Wnt signaling in kidney disease WP4150,0.9651190812950293,0.28690740852009855,0.010186298932835158,['WNT5B'],0.9894960016567331,0,0,1
512,EPO Receptor Signaling WP581,0.9710564869286179,0.2709397344228805,0.007957672970362827,['MAP2K1'],0.9894960016567331,0,0,1
513,Glycerolipids and Glycerophospholipids WP4722,0.9710564869286179,0.2709397344228805,0.007957672970362827,['PLD1'],0.9894960016567331,0,0,1
514,IL-4 signaling pathway WP395,0.9721659111239481,0.40605828220858897,0.011462537480883439,"['CEBPB', 'RPS6KB1', 'EP300']",0.9894960016567331,0,0,3
515,Insulin Signaling WP481,0.972854222850643,0.6232193732193733,0.017151639299728166,"['MAP2K4', 'MAP2K1', 'JUN', 'GSK3A', 'IGF1R', 'INPP4A', 'RPS6KB1', 'RPS6KA2', 'MAP3K9', 'RAC1', 'SGK1', 'GYG1', 'HRAS', 'MAP2K6', 'MAP4K4']",0.9894960016567331,0,0,15
516,Ebola Virus Pathway on Host WP4217,0.9778180372905021,0.5260226910662584,0.011799573834964106,"['CREBBP', 'RASA2', 'EP300', 'RAC1', 'MFGE8', 'MERTK', 'ASGR1', 'IGF1R']",0.9894960016567331,0,0,8
517,p53 transcriptional gene network WP4963,0.979061732949517,0.38460607039070066,0.008138488017124215,"['RRM2B', 'CX3CL1', 'RPRM']",0.9894960016567331,0,0,3
518,Endometrial cancer WP4155,0.97938669412799,0.4234849327254531,0.008820651435937474,"['MAP2K1', 'APC', 'HRAS', 'FGFR2']",0.9894960016567331,0,0,4
519,Cannabinoid receptor signaling WP3869,0.9800722302123833,0.2437946884576098,0.004907344682173907,['PRKAR1A'],0.9894960016567331,0,0,1
520,Nanoparticle triggered autophagic cell death WP2509,0.9800722302123833,0.2437946884576098,0.004907344682173907,['CHAF1A'],0.9894960016567331,0,0,1
521,NRF2 pathway WP2884,0.9819827650919275,0.4936297220242338,0.008974939455643009,"['GSTM4', 'TGFB1', 'SRXN1', 'SLC39A13', 'SLC39A7', 'TXN', 'FTL']",0.9895219801790056,0,0,7
522,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.9886164676900074,0.21192876493316162,0.0024263344227373486,['JUN'],0.9942981715273064,0,0,1
523,Autophagy WP4923,0.9946051513342465,0.1804562478719782,0.0009761696658456553,['RPTOR'],0.9984086127160219,0,0,1
524,Osteoblast differentiation WP4787,0.9980695010623909,0.30865911582024114,0.0005964419959093855,"['WNT5B', 'PRKCE', 'PPARG', 'FGFR2']",0.9993070174025539,0,0,4
525,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.9993070174025539,0.12807107144777163,8.878178942126848e-05,['TANK'],0.9993070174025539,0,0,1
